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Abbreviations 
°C Degree Celsius 
A  Ampere 
ANR Anterior neural ridge 
AzaC 5’-Aza-2’-deoxy cytidine 
BLBP Brain lipid binding protein 
BMP Bone morphogenetic protein 
bp  Basepair 
BrdU 5’-Bromo-2’-Deoxyuridine 
cDNA Copy Deoxyribonucleic Acid 
CNP 2’,3’-cyclic nucleotide 3’-phosphodiesterase  
CNS Central nervous system  
CP  Crossing point 
Cy3  Cyanine 3 
Cy5  Cyanine 5 
D, d  Day 
DAPI 4’6-Diamidino-2’-phenylindol-dihydrochloride 
DEPC Diethylpyrocarbonate 
Dlx1 Distal-less homeo box 1 
Dlx2 Distal-less homeo box 2 
DMEM Dulbecco’s modified eagle medium 
DMSO Dimethylsulfoxide 
DNA Deoxyribonucleic Acid  
dNTP Desoxynucleosid-triphosphate mix  
E10 Day 10 of embryonic mouse development 
E2F1 E2F transcription factor 1 
EB  Embryoid body 
EDTA Ethylenediaminetetraacetic acid 
EGF  Epidermal growth factor 
EGFP Enhanced green fluorescent protein 
Emx1 Empty spiracles homolog 1 
Emx2 Empty spiracles homolog 2 
En1 Engrailed 
ES cell Embryonic Stem Cell 
EtBr Ethidium bromide 
FACS Fluorescence-activated cell sorting 
FCS  Fetal Calf Serum 
FGF-2  Fibroblast growth factor 2 
FISH Fluorescence in situ hybridisation 
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FITC Fluorescein-isothiocyanate  
FoxG1 Forkhead box 1 
G Gram 
GABA Gamma-amino butyric acid  
Gad67 Glutamate decarboxylase 
GAPDH  Glyceraldehyd-3-phosphat-dehydrogenase  
Gbx2 Gastrulation brain homeo box 2 
GFAP  Glial fibrillary acidic protein 
h Hour 
hES Human embryonic stem cell 
hESNSCs Long-term expandable hES cell derived neural stem cells 
HoxA2 Homeobox A2 
HoxB4 Homeobox B4 
ICM Inner cell mass 
ITSFn Insulin, transferrin, sodium selenite & fibronectin medium 
kb Kilo-bases  
Knockout-DMEM  Knockout- Dulbecco’s Modified Eagle Medium 
Krox20 Early growth response  
l Liter 
L27 Ribosomal protein L27 
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LIF Leukemia inhibitory factor  
Mash1 Achaete-scute homolog 1 
MEF Murine embryonic fibroblast  
mES  Murine embryonic stem cell 
min Minute 
mRNA Messenger ribonucleic acid  
ms  Mouse 
mV Millivolt 
ng Nanogram 
Nkx2.2 NK2 homeobox 2 
NSC Neural stem cell 
Otx2 Orthodenticle homolog 2 
P0  Postnatal day 0 in mouse development 
Pax2 Paired box gene 2 
Pax3 Paired box gene 3 
Pax5 Paired box gene 5 
Pax6 Paired box gene 6 
Pax7 Paired box gene 7 
PBS Phosphate-buffered saline 
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RT Reverse transcription 
SVZ Subventricular zone 
SD Standard deviation 
TH Tyrosine hydroxylase 
Tubb3 Tubulin, beta 3 
vGlut1 Vesicular glutamate transporter 1 
vGlut2 Vesicular glutamate transporter 2 
VPA Valproic acid 
µ Micro 
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1 Introduction  
Embryonic stem cells, this term evokes mixed feelings whenever mentioned. Often 
the related research is condemned for ethical reasons and fear that it will encourage 
reproductive cloning. Human embryonic stem (hES) cells consequently represent an 
ethical and social challenge, a fact reflected in the distinctive laws and regulations 
governing their use worldwide and the ongoing debate surrounding these 
legislations. Still, ten years after the first derivation of hES cell lines, it is clear that the 
availability of these cells, from which all major somatic cell lineages can be 
generated, has profoundly altered our approaches in human biology and medicine. 
A major part of the research is focused on the use of hES cell derivatives in treating 
brain diseases and spinal cord injuries. Yet, these diseases also represent the greatest 
challenges for cell replacement strategies given the complexity of the adult central 
nervous system. However, due to the progressive aging of our society and the 
subsequent increase in neurodegenerative diseases stem cell-based therapies of 
neural repair are of immense importance.  
1.1 Stem cells 
Unlike most cells in the human body stem cells are undifferentiated cells capable of 
self-renewal and differentiation into specialized tissue types under certain 
physiologic or experimental conditions. Hence they enable tissues homeostasis as 
well as repair in response to injury (Blau et al. 2001). The term “progenitor cell”, on 
the other hand, refers to any dividing cell with the capacity to differentiate, including 
putative stem cells whose self-renewal has not yet been demonstrated (Smith 2006). 
Here the term “precursor” is used interchangeably with the term “progenitor”. 
Different types of stem cells are found at distinct sites in the body often throughout 
the lifetime of the organism. The division of stem cells can be either symmetric – 
yielding two identical daughter cells – or asymmetric, resulting in one daughter cell 
with the properties of a stem cell and one more differentiated cell. In case of 
symmetric stem cell division both daughter cells can be stem cells or both can be 
more differentiated cells; in this instance the self-renewal capability is lost (Molofsky 
et al. 2004). 
Regarding the second stem cell characteristic, a stem cell is termed totipotent if it can 
give rise to all cell types of an organism including the extra-embryonic tissues. A 
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pluripotent stem cell, on the other, hand is only capable of generating cells of the 
three germ layers i.e. all somatic cell types (Fig. 1).  
 
Fig. 1. Stem Cell Hierarchy 
Stem cells (SC) differ in their differentiation potential. While totipotent cells can generate a complete 
organism, pluripotent cells give rise to all somatic cell lineages and multipotent stem cells reside in 
different organs (http://www.scq.ubc.ca/ 2008). 
The differentiation potential of multipotent cells – somatic stem cells present in many 
tissues – is limited even further as they usually only differentiate into cells of their 
own germ layer (Table 1). Moreover their self-renewal capacity is restricted. 
Nevertheless, these cells ensure an adequate supply of differentiated cells in many 
tissues, such as the gut and skin, and they have been in clinical use for many years 
for instance in bone marrow transplantations (Jaenisch and Young 2008). 
Table 1: Overview – Developmental options of stem cells (Jaenisch and Young 2008) 
Term Potency 
Totipotent Ability to form all lineages of an organism; in mammals only the zygote and the first cleavage blastomeres are totipotent 
Pluripotent Ability to form all lineages of a body. Example: embryonic stem cells 
Multipotent Ability of (adult) stem cells to form multiple cell types of one lineage. Example: hematopoietic stem cells 
Unipotent Cells form one cell type. Example: spermatogonial stem cells 
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Interestingly, the notion that somatic (i.e. multipotent) stem cells do not differentiate 
into cells of other germ layers has been challenged in recent years (Brazelton et al. 
2000; Mezey et al. 2000). However, since at least some of the reported 
transdifferentiation events following transplantation of somatic stem cells were 
evidently due to cell fusion with host cells, it is not yet clear to what extent somatic 
stem cells are capable of transdifferentiation without prior de-differentiation (as seen 
in iPS cells, see 1.1.1.3) (Terada et al. 2002; Ying et al. 2002). 
1.1.1 Embryonic stem cells 
According to the above definition embryonic stem cells are pluripotent since they are 
capable of forming cells from all three germ layers and continuously self-renew. 
They were first isolated from mice in 1981 (Evans and Kaufman 1981; Martin 1981) 
and at present have been generated from several species (Graves and Moreadith 
1993; Wheeler 1994; Thomson et al. 1995; Pain et al. 1996; Li et al. 2006). The first 
human embryonic stem cells – isolated 10 years ago by James A. Thomson – marked 
the start of the current excitement about (human) embryonic stem cell research and 
the first step towards pharmaceutical and clinical applications in humans (Thomson 
et al. 1998). 
1.1.1.1 Derivation and characteristics of human embryonic stem cells 
Conventionally, embryonic stem cells are isolated at day 5 of human embryonic 
development. At this time point the blastocyst consists of the inner cell mass and an 
outer layer of trophoblast cells. While the former will go on to generate the embryo 
proper the latter will give rise to the extraembryonic tissues including the placenta 
(NIH 2007). To generate ES cells, the inner cell mass is isolated via immunosurgery 
and subsequently its outgrowths are passaged on a feeding layer of irradiated mouse 
embryonic fibroblasts to establish an ES cell line (Solter 1975; Thomson et al. 1998) 
(Fig. 2).  
Under standard culture conditions hES cells are grown in medium containing serum 
replacement (Amit and Itskovitz-Eldor 2002) and fibroblast growth factor 2 (FGF-2). 
Alternatively hES cells are grown on Matrigel in fibroblast-conditioned medium. 
In vitro the pluripotency of hES cells is associated with the expression of several 
markers including Oct3/4, Nanog, Telomerase and Rex1 as well as alkaline 
phosphatase activity and it is demonstrated via embryoid body formation (NIH 
2007). If cultured as a suspension hES cells will spontaneously aggregate to 
structures termed embryoid bodies (EBs), that mirror the first steps of inner cell mass 
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differentiation in vivo. In these EBs, hES cells will differentiate into cells from all three 
germ layers namely ectoderm, endoderm and mesoderm (Murray and Edgar 2004). 
 
Fig. 2. Derivation of human ES cell line.  
(a) Donated human embryo produced by in vitro fertilization at the blastocyst stage. (b) Human 
blastocyst after zona pellucida removal by immunosurgery. (c) Inner cell mass immediately after 
immunosurgery on mitotically inactivated mouse embryonic fibroblast feeder layer (Amit and 
Itskovitz-Eldor 2002) (Scale bar = 50 µm). (d) Schematic overview of hES cell generation: after the 
inner cell mass has been isolated via immunosurgery, it is cultivated on mouse embryonic feeder cells. 
If the inner cell mass cells can be subsequently dissociated and replated, a new ES cell line has been 
established (NIH 2007). 
In vivo pluripotency is proven via transplantation of hES cells to host organisms, 
which results in formation of tumours called teratomas consisting of cells from all 
three germ layers (Evans and Kaufman 1981). The ultimate proof of pluripotency, 
however, is tetraploid aggregation. In this procedure the blastomeres of a two-cell 
embryo are fused thereby generating a one cell tetraploid embryo. When this embryo 
is combined with ES cells the generated offspring is solely derived from the ES cells 
(Nagy et al. 1993; Duncan 2005). For obvious ethical reasons this ultimate evidence 
cannot be provided in humans. 
First clues concerning the quality of the hES cell culture can be gained from 
observing the morphology of the cells. Whereas undifferentiated hES grow in flat, 
relatively compact colonies with a clear edge (Fig. 3), the first signs of differentiation 
are the loss of the sharp outer boundary as well as structures arising in the middle of 
the colony. It is important to keep in mind that the growth and molecular 
characteristics of hES cells are the product of tissue culture selection. Thus the hES 
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cells differ epigentically and biologically from their cells of origin (Jaenisch and 
Young 2008). 
 
Fig. 3. hES cell colony on mouse embryonic fibroblasts  
Human ES cells (H9.2 P50) grow as flat, compact colonies (Scale bar: 280µm & 70µm). 
1.1.1.2 Developments in hES derivation 
When using the classical derivation method as described above, resulting hES cells 
can be contaminated with animal substances through cultivation on mouse fibroblast 
feeder cells and the employment of matrix components of animal origin (Jaenisch 
and Young 2008). This contamination may lead to expression of non-human sialic 
acid that would be immunogenic on cells used for human transplantation (Martin et 
al. 2005). Therefore hES cells cultured in the presence of animal substances would not 
be approved for clinical use and hence new approaches have been developed to 
avoid this exposure and to increase hES cell derivation efficiency. For instance, the 
inner cell mass has recently been isolated via micromanipulation instead of 
immunosurgery and was subsequently cultured on human feeder cells or in 
completely defined medium in the absence of animal cells and derivatives (Inzunza 
et al. 2005; Kim et al. 2005; Ludwig et al. 2006). In addition it has been tried to 
address the ethical issue of destroying an embryo while deriving hES cells via 
creation of mES and hES cells from single cell biopsies at the eight-cell stage, which 
leave the embryo intact (Chung et al. 2006; Klimanskaya et al. 2006) (Fig. 4).  
 
Fig. 4. Derivation of ES cell line from single blastomere  
A single blastomere is removed from an 8-cell stage embryo as routinely done in pre-implantation 
diagnostics. The blastomere is then cultured with other cells to derive a new ES cell line, while the 
embryo continues to develop into a blastocyst (Chung et al. 2006; Klimanskaya et al. 2006; Wade and 
Granberg 2006). 
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However, to date no live offspring have been reported after this procedure was 
applied. 
1.1.1.3 New developments in pluripotent cell derivation 
An immense amount of research is currently focused with increasing success at 
generating cells with the main characteristics of embryonic stem cells – unlimited 
self-renewal and pluripotent differentiation potential.  In the mouse and other 
mammals it has been demonstrated some time ago that somatic cells can be 
reprogrammed through somatic cell nuclear transfer (SCNT). In SCNT the nucleus 
from a donor somatic cell is introduced into an enucleated oocyte. Via activation 
using chemicals or electric shock cell division is stimulated up to the blastocyst stage. 
Subsequently an ES cell line can be derived, or if the blastocyst is transplanted to a 
surrogate mother it can give rise to a clone as demonstrated with the sheep Dolly 
(Wilmut et al. 1997; Hipp and Atala 2004). The first primate ES cells derived via 
SCNT were reported last year (Byrne et al. 2007) and blastocysts have been obtained 
after SCNT of human cells. Yet, from these no hES cell lines were established (French 
et al. 2008). Still, these studies proved that terminal differentiation does not restrict 
the potential of the nucleus (Jaenisch and Young 2008). This notion is supported 
further by the fact that cells with the characteristics of ES cells can be created through 
culture induced reprogramming and from testis (Guan et al. 2006; Jaenisch and 
Young 2008). 
The most striking approach, however, was the establishment of induced pluripotent 
cells – iPS cells. After demonstrating that adult somatic cells could be transformed 
into pluripotent cells via fusion with ES cells, the search was out to identify these 
pluripotency-conferring factors (Tada et al. 2001). The breakthrough came 2006 in the 
study by Takahashi and Yamanka. It showed that via retrovirally transducing just 
four factors namely Oct3/4, Sox2, c-Myc and Klf4 and subsequent selection of cells 
that expressed the marker of pluripotency Fbx15, iPS cells could be derived. This was 
first demonstrated in fetal and then in adult mouse fibroblasts. However, with these 
“first generation” iPS cells no chimeras could be generated (Takahashi and 
Yamanaka 2006). Therefore, adult fibroblasts expressing drug selectable markers 
under the control of Nanog or Oct4 – two of the best studied and most essential 
genes associated with pluripotency – were chosen instead of Fbx15 expression to 
selected for truly reprogrammed cells (Maherali et al. 2007; Okita et al. 2007; Rossant 
2007; Wernig et al. 2007). Using the previously described strategy in combination 
with Nanog or Oct4, three groups derived stable iPS lines. These are almost identical 
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to ES cells in their transcriptional imprinting and chromatin modification and passed 
the  “gold standard” test for pluripotenty by extensively contributing to all adult cell 
types including the germ line (Wernig et al. 2007) (Fig. 5).  
 
Fig. 5. Generation of induced pluripotent stem cells (Takahashi and Yamanaka 2006) 
Fibroblasts were isolated from mice carrying a drug-selectable marker linked to the expression of 
Oct/4 (Wernig et al. 2007) or Nanog (Maherali et al. 2007; Okita et al. 2007) and retrovirally transfected 
with the genes for Oct3/4, Sox2 Klf4 and cMyc. In the next step, transfected cells were subjected to 
antibiotic selection thereby selecting for those cells expressing Oct4 or Nanog. These rare cells were 
expanded to stable iPS cell lines. When iPS cells were injected into blastocysts of normal mice they 
contributed to all cell types of the body including the germ line. Thus, when chimaeric animals were 
crossed with normal mice this resulted in mice carrying the genetic content of an iPS cell (Okita et al. 
2007; Rossant 2007). 
The question of whether the same reprogramming was possible with human cells did 
not remain open for long. In the same year two groups presented evidence that 
human somatic cells can be reprogrammed into iPS cells. Yamanka’s group 
successfully applied the advanced technique, which they had employed in mice, but 
this time omitting the selection transgene (Takahashi et al. 2007; Yu et al. 2007). These 
iPS cells were subjected to various assays comparing them with hES cells including 
morphological studies, surface-marker expression, epigenetic status, formation of 
embryoid bodies in vitro, directed differentiation to neural cells and cardiomyocytes 
as well as teratoma formation in vivo. Importantly genomic DNA analysis together 
with analysis of short tandem repeats demonstrated the genetic origin of 
independent human iPS clones from their parental fibroblast populations (Takahashi 
et al. 2007). Thomson and his team, on the other hand, screened for genes highly 
enriched in hES cells relative to myeloid precursors. This approach resulted in a list 
of 14 genes including Oct4 and Sox2 but not Klf-4 or cMyc. They went on to show 
that out of these 14 genes Oct4, Sox2, Nanog and Lin28 were sufficient to reprogram 
human somatic cells to iPS cells, displaying the main characteristics of ES cells 
including differentiation into the three germ layers (Yu et al. 2007).  
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The intriguing possibility provided by induced pluripotent stem cells is to use non-
controversial adult sources to derive iPS cells and then employ these instead of the 
ethically controversial human embryonic stem cells for treatment of degenerative 
diseases and traumatic injuries. Particularly promising is the potential for derivation 
of patient specific iPS cells to provide tissue-matched cells for transplantation 
medicine – thereby eliminating the concern of immune rejection (Rossant 2007). 
In summary, this reprogramming system offers exciting and powerful approaches 
especially since it is feasible to use nonintegrating adenoviruses for delivering the 
inducing transcription factors (Stadtfeld et al. 2008). Nevertheless hES cells will not 
be obsolete for the foreseeable future as it has to be ensured that iPS cells do not 
differ in clinically important ways from hES cells (Yu et al. 2007). 
1.1.1.4 In vitro differentiation of hES cells 
In order to realize their therapeutic potential ES cells have to be differentiated into 
pure somatic cell populations, eliminating all hES cells in the process as these may 
cause the formation of teratomas after transplantation (Thomson et al. 1998; 
Reubinoff et al. 2000; Amit and Itskovitz-Eldor 2002). The widely used differentiation 
strategies of lineage-selection, over-expression of instructive factors, directed 
differentiation and co-culture are illustrated below (Fig. 6).  
The lineage selection approach is based on selecting the desired phenotype from a 
pool of heterogeneously differentiating hES cells. From this starting population 
relevant cells can be segregated, exploiting the distinctive expression of surface 
antigens on different cell types e.g. via immunopanning or fluorescence-activated 
cell sorting (FACSorting). In immunopanning the antibody against the desired 
surface antigen is anchored to a surface, whereas FACSorting isolates the desired 
cells as part of an antigen-antibody complex (Li et al. 1998; Roy et al. 2000; Wang et 
al. 2000; Keyoung et al. 2001; Schmandt et al. 2005). Alternatively, hES cells are 
genetically modified with a selection marker under the control of a promoter only 
expressed in the desired cell type. Drug-resistance genes as well as fluorescence-
conferring genes such as EGFP are commonly employed as selectable markers. In the 
second step the cell population can be enriched for the desired cell type via 
application of the drug thereby killing all non-expressing cells or via isolation using 
FACSorting (Klug et al. 1996; Li et al. 1998; Pasumarthi and Field 2002; Glaser et al. 
2005). 
Introduction 
 
 
19 
 
Fig. 6. In vitro differentiation strategies for ES cells 
Enriched somatic cell populations can be generated from ES cells via co-culture, directed 
differentiation, over-expression of instructive factors and lineage selection (Terstegge 2006). 
A second possibility to substantially enrich for neural subtypes is activation of key 
determinants i.e. over-expression of instructive factors. Examples of this strategy are 
the overexpression of Nurr1 or Lmx1 in mES cells that resulted in enhanced 
differentiation into midbrain dopaminergic neurons and oligodendrocytes (Chung et 
al. 2002; Andersson et al. 2006; Scheffler et al. 2006). 
The aim of directed differentiation in vitro, on the other hand, is to induce the entire 
cell population to differentiate into the desired cell type. Initial differentiation is 
often accomplished via formation of embryoid bodies (EBs) (Bhattacharya et al. 
2005), which are then cultured in specific media and with the addition of extrinsic 
factors in a pre-determined sequence (Bain et al. 1995; Brustle et al. 1999; Bibel et al. 
2004).  
In addition co-culture can be used to regulate the differentiation of ES cells. This 
approach could also be classified as a direct differentiation method, because it is 
often used in combination with that method (Table 2). However, as the co-culture 
method is of central relevance in this work, it was depicted separately in Fig. 6. It has 
been demonstrated that astrocytic co-culture accelerates onset of synaptic activity 
(Johnson et al. 2007) and stromal cell-derived inducing activity promotes 
differentiation of neural cells from mouse embryonic stem cells (Kawasaki et al. 
2000). Additionally other co-culture settings have proven to be effective i.e. non-cell 
autonomous signals were capable of exerting an influence on cell differentiation. For 
instance, telomerase-immortalized fetal midbrain astrocytes enriched hES 
populations for dopaminergic neurons (Roy et al. 2006, 2007). 
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Using these different strategies clinically relevant cell types such as cardiomyocytes, 
neurons, glia and insulin-producing cells have already been derived from hES cells 
(Assady et al. 2001; Zhang et al. 2001; Kehat et al. 2004; Hoffman and Carpenter 
2005). Additionally ES cell derivatives have been used successfully in animal models 
to repair heart damage (Cai et al. 2007), to reverse functional deficits in Parkinsonian 
rats (Yang et al. 2008) and to reduce blood glucose levels in hyperglycaemic mice 
(Shim et al. 2007). However, most of these cell populations lack the purity and 
homogeneity necessary for human cell replacement therapies. Other challenges 
include concerns about tumour formation, immune rejection, heart arrhythmia and 
seizure activity in the central nervous system after transplantation. In addition more 
research is needed to determine the right graft size and the correct model for 
preclinical testing (Murry and Keller 2008). 
Even though the application of hES cells in the clinic is still some way off, the 
characteristics of hES cells make them vital for research and development in the 
pharmaceutical industry. For example, uniformly differentiated hES can serve as 
model with minimal deviation of original characteristics for toxicity testing 
(Klimanskaya et al. 2008). Finally a wide range of hES cell lines harbouring genetic 
disorders such as Duchenne muscular dystrophy, fragile-X syndrome, Huntington’s 
disease and others have been generated and are available to study these diseases in 
vitro (Verlinsky et al. 2005). 
1.1.2 Neural stem cells  
1.1.2.1 Endogenous neural stem cells 
By now the hypothesis that one variety of neural stem cell gives rise to neurons, 
astrocytes and oligodendrocytes has been firmly established by several studies 
proving that primary stem cells isolated from the different sites of the embryonic 
brain (Fig. 7) differentiate into these three cell types (Davis and Temple 1994; McKay 
1997).  
Central nervous system (CNS) stem cells undergo repeated asymmetric cell divisions 
and over time alter their responses to growth factors (Fig. 8) thus producing diverse 
neural and glial subtypes (Allen 2008). During embryonic development early neural 
progenitors proliferate in response to growth factors such as FGF and are highly 
neurogenic (Fig. 8). Late foetal neural stem cells, on the other hand, proliferate 
mainly in response to EGF and predominantly generate glial cells (Fig. 8). Currently 
the mechanisms regulating this temporal responsiveness to patterning cues are still 
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poorly understood, but it is clear that integration of both intrinsic and extrinsic 
signals is involved (Edlund and Jessell 1999; Allen 2008). Especially cell autonomous 
mechanisms e.g. epigenetic determinants seem to play an essential role in 
establishing the required competence for an appropriate response to patterning and 
differentiation cues (Kobayashi et al. 2002; Allen 2008). 
 
Fig. 7. Locations of neural stem cells 
The principal regions of embryonic nervous system from which neural stem cells have been isolated 
(Temple 2001). 
 
Fig. 8. Developmental potential of neural stem cells is temporally regulated 
First neural stem cells divide symmetrically but then switch to asymmetric division passing through a 
neurogenic phase (responsive to FGF) followed by a gliogenic phase (influenced by EGF)(Temple 
2001; Allen 2008). 
Multipotent neural precursors cells have also been isolated from the adult rodent 
brain (Reynolds and Weiss 1992; Gage et al. 1998) as well as from fetal and adult 
human brain (Zhao et al. 2008). In the adult brain neurogenesis is restricted under 
normal conditions to the subgranular zone (SGZ) of the dendate gyrus in the 
hippocampus and the subventricular zone (SVZ) of the lateral ventricles (Kuhn et al. 
1997; Eriksson et al. 1998). Neurons born in the adult SVZ migrate over great 
distances along the rostral migratory stream to the olfactory bulb, whereas neurons 
born in the adult SGZ migrate to the granule cell layer of the dentate gyrus. Both 
types of newborn neurons integrate into existing circuits and receive functional input 
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(Zhao et al. 2008). Whether or not neurogenesis also occurs in other areas of the adult 
mammalian brain remains controversial, but isolation of proliferative precursors 
from adult neocortox as well as adult temporal cortex has been reported (Palmer et 
al. 1999; Walton et al. 2006; Gould 2007).  
In order to proliferate multipotent CNS cells – especially those derived from adult 
organisms – in vitro they are often grown as floating cell clusters termed 
neurospheres (Reynolds and Weiss 1992; Vaccarino et al. 2001). Neurospheres 
predominantly consist of committed progenitors intermingled with differentiated 
astrocytes and neurons, which seem to provide a niche for the maintenance of a few 
stem cells (Garcion et al. 2004). Typically proliferation is promoted through the 
addition of growth factors such as fibroblast growth factor-2 (FGF-2) and epidermal 
growth factor (EGF) (Fig. 8) (Vaccarino et al. 2001). Upon withdrawal of these factors 
from the cultures, the multipotent cells spontaneously differentiate into glial cells 
and neurons, although the efficiency of neuronal differentiation tends to decline with 
increasing passage number (Cattaneo and McKay 1990; Vaccarino et al. 2001). 
Further disadvantages of this culture system include that stem cells maintained 
within neurospheres are not directly accessible and have not yet been purified 
(Suslov et al. 2002).   
1.1.2.2 ES cell derived neural cells  
In principle there are two strategies of using ES cell derived neural cells in cell 
replacement therapies. In the first approach the desired fully differentiated cells are 
generated in vitro and subsequently transplanted. In the second approach the ES cell 
derived neural stem cells are transplanted, relying on the host environment to 
provide appropriate signals to direct differentiation into the desired neural fate.  
Utilizing the first strategy – generating differentiated cells in vitro – it was 
demonstrated in 1996 that neural cells could be generated from ES cells via EB 
formation and subsequent exposure to RA (Bain et al. 1996; Okabe et al. 1996). Since 
then a variety of neural cell types with specific transmitter profiles have been derived 
from hES cells via directed differentiation using growth factor combinations as 
summarized in Table 2.  
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Table 2 Examples for neural subtype specification from human embryonic stem cells 
 (Trounson 2006) 
Primary inducer Tissue Type Reference 
Noggin Neuroectoderm (Pera et al. 2004) 
SDIA + GFs Midbrain neural cells (Perrier et al. 2004) 
FGF2, FGF8, Shh Midbrain TH neurons (Perrier et al. 2004; Yan et al. 2005) 
FGF2 TH neurons (Schulz et al. 2003; Schulz et al. 2004) 
SDIA + BMP4, Shh Neural crest (Trounson 2004) 
bFGF, EGF, RA Oligodendrocytes (Nistor et al. 2005) 
RA, FGF, SHH, BDNF, GDNF, 
IGF1 
Motoneurons (Li et al. 2005) 
 
GFs, growth factors; EGF, epidermal growth factor; VEGF, vascular endothelial growth factor; GDNF, 
glial-derived neurotrophic factor; SCF, stem cell factor; GSCF, granulocyte stem cell factor; EB, 
embryoid body; SDIA, stromal cell derived inducing activity 
Employing immature neural progenitors for transplantation appears to be a more 
promising option than using fully differentiated neural cells, since the precursors 
should integrate more readily into the highly complex CNS. Hence, in addition to 
differentiated neural cell populations, neural precursor cells have been generated 
from ES cells. These neural precursors are capable of proliferation and generation of 
neurons, astrocytes and oligodendrocytes (Conti et al. 2005; Glaser et al. 2007; Koch 
et al. 2009). A protocol used for this purpose begins with embryoid body formation 
in defined medium. In the next step the EBs are plated on adhesive substrates in 
minimal serum free medium – termed ITSFn – which does not support the survival 
of non-neuroectodermal cells including undifferentiated ES cells. Finally plating on 
laminin substrates in the presence of FGF2 promotes proliferation of tri-potential 
neural stem cells (NSCs) (Okabe et al. 1996; Brustle et al. 1999; Zhang et al. 2001; 
Conti et al. 2005). The long-term expandable human embryonic stem cell derived 
neural stem cells (hESNSCs) (Fig. 9) employed here were generated using a protocol 
based on this procedure (Koch et al. 2009). 
In addition to the above described technique NSC differentiation from mouse ES 
cells can be achieved directly without EB formation through culture at low and very 
low densities under feeder-free conditions (Tropepe et al. 2001; Glaser et al. 2007). 
This direct differentiation protocol has been adapted to create NSCs from hES cells 
(Benzing et al. 2006). 
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Fig. 9. hESNSCs in their proliferative and differentiated state 
Homogenous long-term expandable human embryonic stem cell derived neural stem cells (hESNSCs) 
used here maintain their characteristic morphology and robust neurogenic potential over the passages 
in vitro (scale bar top: 90µm, bottom: 50 &120µm). 
In summary, once the complex inductive interactions regulating ES cell neurogenesis 
are uncovered, the addition of appropriate factors at the correct stage might allow 
optimization of NSC production as well as the derivation of desired neural cell types 
from undifferentiated ES cells (Cai and Grabel 2007). 
1.2 Development and specification of the nervous system  
The vertebrate central nervous system initially arises from the dorsal region of the 
embryonic ectoderm. This process of neural plate induction requires active 
repression of bone morphogenetic protein (BMP) signalling from the non-neural 
ectoderm by diffusible factors such as noggin, chordin and follistatin (Smith and 
Harland 1992; Lamb et al. 1993; Hemmati-Brivanlou et al. 1994; Stern 2001; Liu and 
Niswander 2005). Following induction, the neural plate rolls up and forms the neural 
tube, which consists of neural stem cells and in turn gives rise to the central nervous 
system (CNS) including the brain and spinal cord (Lumsden and Krumlauf 1996). 
Grafting experiments in chick embryos gave insights into mechanisms of subsequent 
CNS development. For instance duplication of a brain region was accomplished via 
application of FGF8 (Crossley et al. 1996) suggesting that a single factor is sufficient 
to bias the differentiation cascade and establish major regional features of the CNS 
(McKay 1997).  
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1.2.1 Regionalisation and patterning 
Initially the neural plate is anterior in character and posterior regions form during 
anteriorposterior patterning (Wilson and Maden 2005). The initiation of patterning 
along the anteroposterior axis is marked by the appearance of several vesicles at the 
anterior end of the neural tube namely the prosencephalon (or forebrain), the 
mesencephalon (or midbrain) and the rhombencephalon (or hindbrain) (Lumsden 
and Krumlauf 1996). Meanwhile the underlying meso-endodermal tissue as well as 
the non-neural ectoderm participate in patterning along the dorsoventral axis (Wurst 
and Bally-Cuif 2001). This dorso-ventral patterning has been elucidated in detail. It 
leads to the generation of cellular and regional diversity due to interplay of extrinsic 
mechanisms and expression of regulatory genes in a graded and restricted fashion. 
The patterning depends on the ratio between ventralizing factors of the sonic 
hedgehog (Shh) family, emanating from the notochord and floor plate (Beadle and 
Tatum 1941; Mohler 1988; Tabata et al. 1992) as well as dorsalizing factors of the bone 
morphogenetic protein (BMP) family produced by the roof plate (Sulston et al. 1983). 
In the next step the ventricular zone is progressively subdivided into zones 
expressing distinctive homeodomain transcription factors, from which different 
subclasses of neuron as well as glia later emerge (Anderson 2001) (Fig. 10). 
 
In contrast patterning events along the anteroposterior axis are less well understood. 
Local signalling centres acting as secondary organizers account at least in part for the 
induction and maintenance of refined patterning in the rhombencephalon and 
possibly in the prosencephalon. Two such signalling centres have been identified so 
far: the anterior neural ridge (ANR), positioned at the junction between 
prosencephalon and anterior ectoderm, and the isthmic organizer (IsO), which marks 
Fig. 10. Schematic illustration of dorso-ventral patterning  
The dorsoventral axis is initially specified by opposing 
diffusion gradients of Sonic hedgehog (Shh) and bone 
morphogenetic proteins (BMPs) secreted by signalling centres 
at the ventral (floorplate) and dorsal (roofplate) midline, 
respectively (Liu and Niswander 2005). 
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the boundary between midbrain and hindbrain (Shimamura and Rubenstein 1997; 
Houart et al. 1998). The IsO, which is found in all vertebrate species, is necessary and 
sufficient for the development of mesencephalic and metencephalic structures 
(Wurst and Bally-Cuif 2001). When grafted to ectopic neural locations such as the 
diencephalic prosomere 1 the IsO induced mesencephalic and metencephalic 
structures in clear rostrocaudal polarity i.e. the posterior side of the induced 
mesencephalon and the rostral side of the induced metencephalon were in contact 
with the graft (Marin and Puelles 1994; Wurst and Bally-Cuif 2001). 
Removal of the ANR, on the other hand, results in a failure to express FoxG1 
(previously Bf1). This transcription factor, which selectively marks future cortical 
progenitors before the telencephalon is morphologically distinguishable is required 
for normal cortical morphogenesis (Tao and Lai 1992; Xuan et al. 1995; Shimamura 
and Rubenstein 1997).  
Furthermore as discussed above with regard to BMPs and Shh in dorsoventral 
patterning, single factors, which play a role in anteriorposterior patterning, have 
been identified. One example is retinoic acid (RA). As a patterning factor RA in 
conjunction with FGFs and WNTs is involved in the organization of the posterior 
hindbrain and spinal cord (Liu et al. 2001). In the absence of RA signalling these 
structures are not developed (Maden 2007). Overall patterning events result in the 
establishment of a rough three-dimensional grid in the embryonic neural axis, 
conferring a positional identity on precursor cells in the CNS (Kiecker and Lumsden 
2005). This identity is reflected by the expression of distinctive regional transcription 
factors. Some of these transcription factors were used as candidate markers 
representative of the brain region where they are found in vivo (Table 3 and Table 4).  
Table 3 Region specific expression of candidate transcription factors 
Brain Region Forebrain Midbrain Hindbrain 
Candidate 
transcription factors 
FoxG1, Emx1, Emx2, 
Otx2, Dlx1, Dlx2 
En1, Pax2, Pax5 
Gbx2, HoxA2, 
HoxB4, Krox20 
In this context, it should be noted that some of the candidate markers change their 
expression with stage of development and upon differentiation (Pasini and 
Wilkinson 2002; Mo and Zecevic 2008). 
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1.2.2 Plasticity and regional gene expression in neural progenitors 
1.2.2.1 Endogenous neural progenitors 
Transplantations of P0 neural progenitors into the adult rat brain resulted in 
inefficient heterotopic neuronal integration thereby limiting the possibilities of this 
approach (Zigova et al. 1998; Turner and Shetty 2003). The limitation was not seen if 
cells from areas exhibiting postnatal neurogenesis (i.e. the hippocampus, olfactory 
bulb and cerebellum) were used or if precursor cells were transplanted into these 
areas, suggesting that local guidance cues might be maintained in these regions 
(Renfranz et al. 1991; Vicario-Abejon et al. 1995; Suhonen et al. 1996). Moreover 
grafting neural cells across the uterine wall into the embryonic mammalian brain 
revealed a remarkable plasticity of transplanted neuroepithelial precursor cells 
(Brustle et al. 1995; Campbell et al. 1995; McKay 2004). For instance striatal 
precursors injected into the embryonic mouse brain were incorporated into cortex 
and various other host brain regions, suggesting that they were not restricted to a 
striatal fate (Fishell 1995). Furthermore, transplanted precursor cells from ventral and 
dorsal mouse telencephalon were shown to participate in the generation of 
telencephalic, diencephalic, and mesencephalic brain regions, generating widespread 
CNS chimerism (Brustle et al. 1995). Additional grafting experiments showed that 
immortalized hippocampal cells transplanted to the developing cerebellum 
differentiated into typical cerebellar neurons (Renfranz et al. 1991). Moreover 
primary cerebellar cells grafted into the hippocampus of neonatal rats and wild type 
mice acquired morphological and immunohistochemical features of hippocampal 
granule neurons (Vicario-Abejon et al. 1995). Therefore, these studies suggest that 
precursor cells originating in a distinct part of the neuroepithelium are not restricted 
to a local fate but are capable of migration and differentiation upon heterotopic 
transplantation thereby responding to signals of their new environment. 
In this context it is important to note that growth factor mediated expansion of 
neural precursors in vitro has been reported to compromise positional identity 
information. Specifically a candidate transcription factor expression analysis of 
neurospheres and stem progenitor cells expanded in the presence of EGF and FGF-2 
revealed profound changes in expression patterns of region specific transcription 
factors compared with primary precursors in vivo (Santa-Olalla et al. 2003; Hack et al. 
2004). In accordance with these results Dr. Jakupoglu of our group found a blurring 
of the region specific transcriptional code after cultivation of primary neural cells in 
EGF and FGF (Jakupoglu, C., unpublished data). Furthermore neural subtypes that 
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occur only in specific regions such as dopaminergic neurons are difficult to produce 
in vitro even if the neurospheres originated from the region generating dopamine 
neurons in vivo (Hitoshi et al. 2002; Parmar et al. 2002; Ciccolini et al. 2003; Machon et 
al. 2005; Yan et al. 2005). However, since not all reports confirmed the observation 
that propagation in EGF and FGF alters the original region specific code (Hitoshi et 
al. 2002) an explanation for the different results could be the effect of cell density. As 
long as cells still interact with their normal neighbours they might still receive 
positional information that is only partially overridden by the potent growth factor 
signalling of EGF and FGF. This phenomenon, termed “community effect” may 
account for the maintenance of some regional differences in high-density 
neurosphere cultures (Ostenfeld et al. 2002; Parmar et al. 2002; Hack et al. 2004). 
Nevertheless, these outcomes underline the concept that regionalisation and 
neurogenesis are inseparably linked and the loss of regionalization impairs the 
generation of distinct phenotypes (Goetz 1998; Hack et al. 2004). The notion that 
maintenance of positional identity requires ongoing interaction with environmental 
cues was further supported by a study from Jensen and co-workers suggesting that 
impaired regionalization may be restored by co-culture with non-expanded primary 
cells. It was demonstrated that expanded neural precursors derived from the lateral 
ganglionic eminence (LGE) regain their potential to differentiate into striatal 
projection neurons upon co-culture with primary LGE cells (Jensen et al. 2004). The 
phenomenon seemed dependent on cell-to-cell contact and could not be mimicked 
by conditioned media (Eriksson and Wictorin 2003). This suggests that during 
development neural precursors can be regionally specified by their environment and 
that through mimicking such an environment one can achieve the same 
differentiation behaviour in vitro.  
1.2.2.2 ES cell-derived neural progenitors 
Several studies have demonstrated the potential of hES and mES cell derived neural 
precursors to incorporate into the CNS, where they differentiate into neurons and 
glia morphologically indistinguishable from neighbouring host cells (Brustle et al. 
1997; McDonald et al. 1999; Reubinoff et al. 2001; Zhang et al. 2001). 
When investigated in more detail, it was revealed that at single cell level grafted mES 
cells derived neurons exhibited morphological and functional integration into a large 
variety of regions of the developing rodent brain. Yet, many of the incorporated 
neurons failed to express appropriate region specific genes. Hence it was concluded 
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that lack of an appropriate regional code does not prelude morphological and 
synaptic integration of ES cell derived neurons (Wernig et al. 2004).  
In vitro the responsiveness and potential of both mouse and human ES cell derived 
neural progenitors for directed differentiation seems temporally regulated (Li et al. 
2005; Bouhon et al. 2006). The mechanisms that limit temporal responsiveness to 
patterning cues are unknown. However, since extrinsic cues conferred by the spatial 
organization and interaction of cells in vivo are absent in vitro, it has been suggested 
that temporal responsiveness is a mainly intrinsic property (Allen 2008). 
So if the herein used hES cell-derived neural progenitors are as pliable as early 
mouse derived neural progenitors it might be possible to guide their region specific 
gene expression using a co-culture approach. Through combining this approach of 
regional pre-specification with the controlled generation of neuronal, astrocytic and 
oligodendroglial subpopulations, regionally defined donor cells may be created for 
future regenerative therapies.  
1.3 Epigenetic regulation of developmental potential  
The term epigenetics refers to a collection of mechanisms that together define the 
phenotype of a cell without affecting its genotype (Sasaki and Matsui 2008). It is clear 
that epigenetic changes via coordinating fate-determining gene expression influence 
the developmental potential of both embryonic and neural stem cells thus regulating 
neural lineage progression.  
Gene expression is not only dependent on the presence of appropriate transcription 
factors interacting with enhancer as well as promoter elements in a cell-type or 
tissue-specific manner but is also based on the availability of binding sites regulated 
by higher orders of chromatin structure (Allen 2008). These specific patterns and 
their alterations are somatically heritable and the propagation of epigenetic status to 
the next cell generation is important for establishing cell type specific gene 
expression and maintaining cell identity (Avots et al. 2002; Jaenisch and Bird 2003). It 
has been known for some time that in transcriptionally active chromatin domains the 
histones are hyperacetylated and the DNA is demethylated (or showing very little 
methylation). In contrast, in inactive chromatin regions the DNA is methylated and 
the histones are hypoacetylated (Cedar 1988). Apart from these two modifications 
histone methylation, phosphorylation, ubiquination and sumoylation as well as 
polycomb-trithorax proteins affect the epigenetic status (Jenuwein and Allis 2001).  
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Histone acetylation occurs reversibly on lysine e-NH3+ groups of core histones, 
effecting a change in electrostatic charge and a subsequent loosening of the 
chromatin. The level of histone acetylation depends on the opposing activities of 
histone acetyltransferases (HATs) and deacetylases (HDACs) (Eberharter and Becker 
2002). For the latter enzyme family several specific inhibitors are known for instance 
trichostatin A (TSA) (Yoshida et al. 1990) and valproic acid (2-propylpentanoic acid, 
VPA). VPA is a well-tolerated anticonvulsant inhibiting both class I and II HDACs 
resulting in hyperacetylation of histone H3 and H4 (Kramer et al. 2003). In addition 
to its HDACs inhibiting properties, VPA has been reported to modulate GABA levels 
in the brain and to activate ERK pathway mediated neurotropic actions (Biggs et al. 
1994; Hao et al. 2004). 
AzaC, on the other hand, is often used as a DNA methylation inhibitor. When 
incorporated into DNA, it covalently binds to and irreversibly blocks the 
ubiquitously expressed maintenance methyltransferase Dnmt1, allowing passive 
demethylation to take place as cells divide (Pietrobono et al. 2002). Treatment with 
AzaC in combination with TSA resulted in a synergist reactivation of silenced genes 
in tumour cells (Cameron et al 1999). This result might suggest that epigenetic 
modifications can influence the developmental potential of a cell.  
1.4 Aim  
Future application of human embryonic stem cell derived neural precursors will 
depend critically on the ability of patterning the cells in a predictable manner. This 
capacity may then result in generation of regionally defined cell types capable of 
functionally integrating into their new environment. So far only few regionally 
specified cell populations relevant to transplantation strategies of neurodegenerative 
disorders have been obtained in vitro, e.g. dopaminergic neurons and motoneurons 
(Perrier et al. 2004; Li et al. 2005). Therefore the purpose of this work was to 
systematically investigate whether primary cells from different regions of the 
developing rodent brain – which themselves are known to be regionally specified 
(Zappone et al. 2000; Hitoshi et al. 2002) – can influence the regional identity of 
human ES cell-derived neural stem cells in vitro. 
As a basis for all experiments the first aim was to investigate the ground state of 
regional gene expression of the hES cell derived neural stem cells established in our 
group. As readout of this and the following investigations human specific 
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quantitative RT-PCR expression analysis of region specific transcription factors was 
used.  
To subsequently investigate the main objective – whether regionalisation cues from 
primary cells can be utilized to prime the regional identity of the hESNSCs –
paradigmatic co-culture settings were chosen. In these, hESNSCs were exposed to 
forebrain, midbrain, hindbrain/cerebellum and spinal cord of embryonic and P0 
mice as well as hippocampal and cerebellar slices of 9-day-old rats. The influence of 
both – cell-mediated and diffusible – cues was assessed.  
Since it is known that the developmental potential of ES cells can be in part ascribed 
to their dynamic epigenetic state, a further question to be addressed was whether 
DNA demethylation and histone hyperacetylation alter the response of hESNSCs to 
primary cell derived cues. 
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2 Materials and Methods 
2.1 General  
All work involving human embryonic stem cells was approved by the Robert-Koch-
Institute and was carried out in accordance with the German Stem Cell law.  
Materials and solutions for the cell culture were appropriately sterilized 
(autoclaving, heat-sterilisation, sterile filtration) prior to use or bought sterile from 
the manufacturer. A complete list of the used equipment, materials, chemicals, 
antibodies and primers can be found in the appendix. 
2.2 Cell types 
The human embryonic stem cell lines were provided by Joseph Itskovitz-Eldor, 
Haifa, Israel. The human embryonic stem cell derived neural precursors of the H9.2 
line used in this work were established by myself whereas the I3 hES-derived neural 
precursors – including a EGFP over-expressing line – were kindly provided by Dr. 
Koch.  
For the co-cultures primary cells derived from embryonic and neonatal brains of 
C57B6 mice were used. For the slice cultures, brains of 9-day old Wistar rats were 
employed. 
2.3 Human embryonic stem cells  
To preserve the undifferentiated state of hES cells, they are cultured on mitotically inactivated 
mouse fibroblasts under standard conditions.  
2.3.1 Culture of murine embryonic fibroblasts 
The serum-free medium used for cultivation of hES cells is not suitable for fibroblasts. Under 
serum-free conditions they develop a spindle-like appearance and detach from the tissue 
culture dish after approximately one week. Therefore, the fibroblasts are thawed in medium 
supplemented with serum and are only cultured under serum-free conditions when they serve 
as feeder cells for hES cells.  
Vials with cryopreserved murine embryonic fibroblasts were thawed in a water bath 
at 37°C, transferred in 5ml MEF Medium, centrifuged at 1200 rpm for 5 minutes, and 
plated on one 15cm dish per vial. The cells were cultured at 37°C and 5% CO2. When 
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they had reached confluence, cells were washed twice in PBS, incubated with 
trypsin/EDTA for 5 minutes at 37°C and washed of with FCS containing MEF-
Medium.  The cell suspension was spun down at 1200 rpm for 5min and re-plated 
onto 15cm dishes in a 1:3 ratio. In this way the cells were cultured for up to 4 
passages.  
2.3.2 Mitotic inactivation of murine embryonic fibroblasts via γ-irradiation 
A prerequisite for the culture of hES cells on fibroblasts is the mitotic inactivation of the 
feeder cells since fibroblasts proliferate faster than hES cells and would otherwise outgrow the 
stem cells. 
For γ-irradiation confluent 15 cm dishes were trypsinized as described above (2.3.1). 
The cell pellets of 24-26 dishes were pooled in 35ml MEF Medium and transferred to 
a T175 culture flask. The γ-irradiation was carried out in the therapeutic radiology 
unit at the University of Bonn medical centre either on a linear accelerator  
(MEVATRON MD2, Siemens) using 6MV photons at maximal dosage (17mm) or in a 
tissue equivalent solid phantom (RW3, PTW Freiburg) at a focus-tissue–distance of 
100 cm. After irradiating the fibroblasts with 15 Gy, they were plated onto gelatine 
coated 15cm cell culture dishes. After 24h the irradiated fibroblasts were frozen at a 
concentration of 2.4x106 cells per vial. 
2.3.3 Thawing of mitotically inactivated murine embryonic fibroblasts 
Vials with cryopreserved γ-irradiated murine embryonic fibroblasts were thawed in a 
water bath at 37°C, transferred in 5ml MEF-Medium, centrifuged at 1200 rpm for 5 
minutes and plated onto two gelatine-coated six-well tissue culture plates per vial. 
This results in 2x105 fibroblasts per well of a six-well tissue culture plate. They were 
cultured at 37°C and 5% CO2. No less than eight hours and no longer than three days 
after plating, hES cells were seeded on the mitotically inactivated fibroblasts.  
2.3.4 Thawing of human embryonic stem cells 
Both freezing and thawing of hES cells is an inefficient process, because survival rates are low 
and spontaneous differentiation rates are high. Therefore, human ES cells are kept as 
permanent cultures and thawed as seldom as possible. 
The hES cells were thawed quickly in a water bath at 37°C, transferred to a Falcon 
tube and 5ml hES cell medium were added slowly and cautiously. While the hES 
cells were centrifuged at 800 rpm for 3 minutes the medium of one well of a six-well 
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plate containing irradiated fibroblasts was changed from MEF medium to hES cell 
medium. The hES cell pellet was re-suspended cautiously in 1ml hES cell medium. 
Subsequently the cells were seeded homogenously onto the previously prepared 
fibroblast feeder layer and incubated at 37°C/ 5% CO2. 
2.3.5 Passaging of human ES cells 
Human ES cells are usually passaged as small aggregates, since this approach increases the 
plating efficiency and reduces spontaneous differentiation as well as karyotypic abnormalities. 
Thus, the application of trypsin, which dissolves hES cell aggregates, is not suitable. Instead a 
combination of collagenase IV treatment and mechanical methods is employed. 
HES cell culture medium was changed every day and the cells were passaged every 
three to six days. In order to do so, the medium was aspirated and 1mg/ml 
collagenase IV (0.5ml/well) was administered for 45 minutes. Afterwards the 
collagenase was diluted with 1ml hES medium per well and the hES cell colonies 
were rinsed of the tissue culture plate. Following centrifugation at 800 rpm for 3 
minutes 1ml hES cell medium was added to the cell pellet which was then re-
suspended using a 1000µl Eppendorf pipette until only small aggregates remained 
visible. Finally, the cells were seeded homogenously in ratios between 1:1 and 1:6 in 
hES cell medium onto the previously prepared fibroblast feeder layer (see 2.3.3) and 
incubated at 37°C/ 5% CO2. 
2.3.6 Freezing of human ES cells 
Human ES cells were detached from the tissue culture plates by collagenase IV 
treatment and centrifuged as described in 2.3.5. Depending on the density of the 
culture one to three wells were frozen per cryovial. The pellet was cautiously re-
suspended in 0.5ml hES medium per cryovial employing a 5ml plastic pipette in 
order to preserve the cell aggregates (colonies). Subsequently the cell suspension was 
aliquoted into cryovials and 0.5ml hES freezing medium were added drop wise to 
each vial. The cells were slowly frozen down at 1°C per minute to -80°C in a freezing 
container and transferred to liquid nitrogen on the next day. 
2.3.7 Induction of multi-lineage differentiation from hES in vitro 
When grown as aggregates in suspension culture under favourable conditions ES cells form 
structures termed embryoid bodies (EBs), which consist of cells from all three germ layers. 
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This is generally considered as indication for the maintenance of the hES cell state. Moreover 
it is the first step in deriving human embryonic stem cell derived neural precursors.  
Human ES cells were detached from the feeder layer and spun down as described 
above (2.3.5). In the next step the pellet was re-suspended very cautiously in EB 
medium supplemented with FCS in order to preserve the hES cells as aggregates. 
The aggregates where then cultured in suspension in bacterial grade Petri dishes. 
The medium was changed every other day through transferring the EBs into a Flacon 
tube. After the cells had settled at the bottom the medium was aspirated and 
replaced with fresh EB medium. 
2.4 HES cell derived neural precursors 
The hESNSCs established in the course of this project were derived from human embryonic 
stem cells of the H9.2 line in passage 48-52. 
2.4.1 Derivation and culture  
Human neural precursors were derived as described previously (Zhang et al. 2001; 
Koch et al. 2009). Briefly, ES cell colonies were detached from the feeder layer and EB 
formation was induced as described above using serum replacement (2.3.8). After 4 
days the EBs were plated on polyornithine treated tissue culture dishes on which 
they attached. On the next day the medium was changed to ITSFn medium and 
thereafter medium was exchanged every other day. Within 10 to 14 days the 
embryoid bodies generated outgrowths in which neural rosettes like structures 
developed. These structures were mechanically isolated using a gauge needle under 
a dissection microscope at the horizontal hood. They were rinsed off with N2 
medium and transferred to bacterial grade Petri dishes. Thereafter they were 
cultured as free-floating neurospheres in N2 medium at 37°C/ 5% CO2 on a shaker at 
low setting. Medium was changed every other day. After 3 weeks the neurospheres 
were pooled in a 15ml Falcon tube and after addition of 1ml trypsin they were 
incubated for 5 min at 37 °C. In the next step 1ml trypsin inhibitor and 10% DNase 
were added before the neurospheres were triturated to single cells. The cells were 
centrifuged in 7ml N2 medium at 1000 rpm for 4 minutes, resuspended in 1ml N2 
medium and plated onto 1 well of a polyornithine/laminin coated 12-well tissue 
culture dish. From then on cells were proliferated in N2 medium supplemented with 
10 ng/ml FGF2, 10 ng/ml EGF and B27 1:1000. During the first seven days medium 
was changed daily.  
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2.4.2 Propagation  
2.4.2.1 Preparation of polyornithine/laminin coated dishes 
The cells were routinely passaged every three days. In order to do so tissue culture 
dishes were first coated with polyornithine for at least two hours. After this time the 
dishes were washed twice with PBS and subsequently coated in laminin 1µg/ml for 
at least 45 minutes. The treated dishes were used no longer than three days after 
coating. 
2.4.2.2 Passaging of hESNSCs 
Usually hESNSCs were split in a 1:2 or 1:3 ratio every three days. After aspirating 
medium from the cells, 0.5ml trypsin were added per well of a six-well tissue culture 
dish. After incubation for three minutes at room temperature or at 37°C, 0.5ml 
trypsin inhibitor were added to each well, the cells were rinsed off and collected in a 
Falcon tube. While the cells were centrifuged at 1000 rpm for 5 minutes, laminin was 
aspirated from polyornithine/laminin treated six-well tissue culture dishes and 
1,5ml N2 medium supplemented with FGF, EGF and B27 were added per well. In the 
next step the cell pellet was resuspended in 0.5ml N2 medium per well and seeded 
on the prepared tissue culture dishes. On the next day EGF, FGF and B27 were added 
(see 2.4.1). On the second day after passaging the medium was changed completely. 
2.4.3 Induction of differentiation from hESNSCs 
2.4.3.1 Preparation of Matrigel coated dishes  
Matrigel coated dished were routinely used for long-term differentiation of hESNSCs since 
the cells adhered better to this coating than to polyornithine/laminin. 
Matrigel was thawed over night at 4°C and diluted 1:30 in ice-cold Kockout-DMEM 
before coating tissue culture dishes for 2 hours at room temperature or overnight at 
4°C, respectively. After this time the Matrigel-solution was aspirated and cells were 
seeded on the plates as described above (2.4.2.2). 
2.4.3.2 Induction of differentiation 
When cultured in the presence of FGF and EGF the hESNSCs proliferate, whereas upon 
withdrawal of these two factors they will cease proliferating and start to differentiate. 
Matrigel was aspirated and cells were passaged as described above (2.4.2.2) in a ratio 
of 1:2 or 1:3 onto the Matrigel-pre-treated tissue culture dishes. On the next day N2 
medium was exchanged with NGMC medium to induce differentiation. Thereafter 
NGMC medium was changed every other day. 
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2.4.4 Co-cultures and transplantation of hESNSCs  
Non co-cultured hESNSCs of the same passage as co-cultured cells were used as control. They 
were differentiated for the duration of the co-cultures on Matrigel. In the case of the 
organotypic slice model, control cells were cultured on the insert without an orgonotypic slice 
or in the case of re-aggregation co-culture, re-aggregated without rodent cells.  
2.4.4.1 Shared medium co-culture 
Cells were trypsinized as described above (2.4.2.2) and 150.000 hESNSCs were plated 
in each well of a 12-well cell culture plate pre-coated with Matrigel in N2 medium. 
On the next day the medium was changed to NGMC and single cell suspensions of 
the cerebellum, mesencephalon and telencephalon were prepared from newborn (P0) 
C57/B6 mice following a previously described protocol (Polleux and Ghosh 2002). 
The whole dissection procedure was carried out on ice in R6 medium. Briefly, the 
pups were anesthetized using isolfuran. Following cervial dislocation and removal of 
the skull, the brain was dissected out. In the next step the telencephalon, 
mesencephalon and cerebellum were separated under a dissection microscope using 
forceps and cleaned of blood vessels and meninges. Each tissue type was placed in a 
separated 15ml Falcon tube, in which all tissues of the same type were subsequently 
pooled, i.e. the cerebella of all dissected pups were pooled in one Falcon tube. The 
tissue was then digested in papain for 20 minutes at 37°C. After this time the reaction 
was halted using trypsin inhibitor and the tissue was rinsed several times in R6 
medium. Subsequently, a single cell preparation was derived via triturating the 
primary cells to a near single cell suspension in R6 medium supplemented with 
DNase (0.1%) using flamed Pasteur pipettes and passing them through a cell strainer. 
Afterwards the cells were centrifuged at 1000 rpm for 5min and the pellet was re-
suspended in NGMC medium supplemented with 1µg/ml laminin. Finally 200.000 
primary cells of each region were placed in separate cell culture inserts (Falcon, 
0.4µm pore size) above the neural precursor cells (Fig. 11). During the whole culture 
period of 28 days the medium was changed every 3-4 days via carefully inserting a 
Pasteur pipette into the space between insert wall and the wall of the tissue culture 
well.  
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Fig. 11. Shared medium co-culture setup (modified from BD Falcon) 
(a) An insert was used for culturing primary cells and hESNSCs in the same medium (b) in normal 
tissue culture dishes. (c) Medium was changed via carefully inserting a pipette into the space between 
insert and wall of the tissue culture well. 
2.4.4.2 Physical contact co-culture 
In the first experiments hESNSCs expressing EGFP under control of the phosphoglycerate 
kinase (PGK) promoter and a blasticidine drug resistance gene under control of the SV40 
promoter derived from I3 human embryonic stem cells kindly provided by Dr. Koch were 
used.  
In the case of physical contact co-culture with embryonic cells, timed-pregnant 
C57/B6 mice (the day when a vaginal plug was detected was designated as 
embryonic day 0) were anesthetized on the appropriate day using isolfuran. 
Following cervical dislocation, the embryos were removed form the uterus and 
placed in a Petri dish containing PBS. They were freed of the uterus using forceps 
and placed in pairs in 3 cm Petri dishes in R6 medium. Under a dissecting 
microscope the brains were exposed and the following regions, depending on the 
individual experiments, were placed into separated Falcon tubes in R6 medium on 
ice:  
E15: anterior forebrain, midbrain hindbrain organizer region (MHO) (Fig. 12a). 
E12.5: forebrain, midbrain or MHO, hindbrain, spinal cord (Fig. 12b) 
The midbrain-hindbrain boundary was used as anatomical cut-off point to separate 
the midbrain from the hindbrain (Fig. 12).  
All tissues of one type were pooled, i.e. the spinal cords of all embryos dissected at 
one time were pooled in one Falcon tube. In the next step primary cells were slowly 
and carefully resuspended to near single cell suspension in R6 medium in the 
presence of DNAse (0.1%) using flamed Pasteur pipettes. After counting of the cells 
and centrifugation at 1000 rpm for 4 minutes the cell pellet was resuspended in N2 
medium. Cells were plated on polyornithine/laminin coated 12 well plates (each 
region on a separate plate) at densities of 100.000 cells/cm2 (anterior telencephalon, 
spinal cord) or 200.000 cells/ cm2 (midbrain, hindbrain). After 7h, when the primary 
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cells had begun to settle, the cell debris was washed off and 200.000 hESNSCs were 
added per well. On the following day the N2 medium was exchanged with NGMC 
medium. Thereafter medium was changed every other day. 
 
Fig. 12. Areas approximately prepared from a total E14/ E15 and E12.5 mouse brain  
(a) Total E14 mouse brain, indicated are the regions approximately prepared for the different 
experiments (scale bar 600µm). (b) Head of an E12.5 embryo. Primary cells were prepared from the 
highlighted regions (scale bar 700µm). 
In direct co-culture with cells of P0 animals, the primary cell preparation was similar 
to the procedure described in 2.4.4.1 above. 
2.4.4.3 Re-aggregation co-culture  
Primary cells were prepared from the midbrain and hindbrain of E12.5 C57/B6 
embryos as described above (2.4.4.2, for approximate areas see Fig. 12b). After 
centrifugation all cells of one brain region e.g. the midbrain (Fig. 12) were mixed with 
hESNSCs at a ratio of 10:1 in 1ml NGMC medium.  
 
Fig. 13. Re-aggregation co-culture set up (modified from Studer et al 1998) 
Cells were grown as free-floating aggregates at slow rotation. 
Co-cultures were grown as free floating aggregates in 15ml Flacon tubes in a roller 
drum system (Studer et al. 1998) (Fig. 13) for 10 days, while the medium was 
changed every other day.  
2.4.4.4 Transplantation of neural precursors onto organotypic slice cultures  
Organotypic slice cultures of the hippocampus, and cerebellum were prepared by Ms 
Steinfarz from 9 day old Sprague Dawlesy rats as described (Scheffler et al. 2003). 
Briefly, slices (400µm) containing the dentate gyrus, entorhinal cortex, and adjacent 
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areas of the temporal cortex as well as the cerebellum were prepared and cultured in 
interphase conditions at 5% CO2 and 35°C (Stoppini et al., 1991). Cultures were 
started in a horse serum-containing medium, which was gradually replaced until 
day 5 in culture by a serum-free, defined solution based on DMEM supplemented 
with N2 and B27. On day five of culture 200.000 hESNSCs were seeded on each slice. 
Medium was changed every other day throughout the culture period.  
2.4.4.5 Transplantation into neonatal rats 
HESNSCs were trypsinised and centrifuged as described above (2.4.2.2), 
resuspended at 100.000 cells/µl in Cytocoon buffer and placed on ice. CD1 rat pups 
(n=16, P1) were cryo-anesthetized in melting ice and 2 µl of the cell suspension were 
injected by Dr. Koch into the left hippocampus and the cerebellum using a glass 
micropipette (70µm). The pups were subsequently warmed on an electrical blanket 
and when they had regained consciousness returned to their cage. At P20 the animals 
were anesthetized, perfused with ice cold 4% paraformaldehyde at room 
temperature for 5-10 minutes at a low rate of approximately 10ml/min followed by 
perfusion with PBS at the same flow rate for 10min.  The brain was excised; the left 
hippocampus as well as the cerebellum were dissected out and immersed in 4% 
paraformaldehyde. 
2.4.5 DNA demethylation/ histone hyperacetylation  experiments 
2.4.5.1 VPA/AzaC treatment 
Two hours after passaging the hESNSCs at a 1:1 ½ ratio, N2 medium supplemented 
with FGF, EGF and B27 medium (as described in 2.4.1) was changed and 1mM VPA 
and 250-500nM AzaC were added to the culture. Thereafter medium with 
VPA/AzaC was changed every day for 3 days (72h), while control cells were left 
untreated. 
After this time any other treatment was started immediately without passaging the cells 
again, since the survival rate of trypsin application directly following VPA/AzaC treatment 
was very low. 
2.4.5.2 Methylation status analysis 
Commonly the methylation status of a DNA sequence is determined by incubation with 
sodium bisulfite resulting in conversion of unmethylated cytosine residues to uracil and 
leaving methylated cytosines unchanged, thereby giving rise to different sequences for 
methylated and unmethylated DNA.  
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For the methylation status analysis total DNA was extracted with the DNeasy Blood 
and Tissue kit followed by bisulfite treatment using the EpiTect Bisulfite Kit 
according to the manufacturer’s instructions.  Once the DNA was bisulfite treated 
methylation status of heavily methylated long interspersed repetitive elements 
(LINEs) was analysed as indicator for the whole genome. This was done via the 
COBRA assay published by Yang and co-workers. Briefly, 25µl PCR reactions were 
carried out under the conditions as specified in the appendix. The final PCR product 
was digested with HinF1 at 90 minutes at 37°C. This enzyme cut the sequence 
GANTC, which was only present at originally methylated sites since the bisulfite 
treatment converted all unmethylated cytosine residues to uracil. Therefore it was 
possible to distinguish between originally methylated and unmethylated sites using 
this strategy. Finally the digested PCR products were separated by electrophoresis 
on a 3% agarose gel and stained with ethidium bromide. 
2.4.5.3 Western Blot 
Western blot was used to assess the acetylation status of histone 4 in VPA treated cells. The 
employed antibody recognised acetylation on lysines 5, 8, 12 and 16 of histone 4.  
Compositions of all buffers and solutions are listed in the appendix. During protein 
separation a prestained marker containing proteins of 250kDa, 150kDa, 100kDa, 75kDa, 
50kDa  37kDa, 25kDa, 20kDa, 15kDa und 10kDa obtained from Biorad was used. 
Equal amounts of protein were denatured at 95°C for 5 minutes in Laemmli sample 
buffer and separated on a 10% SDS PAGE gel, which was run for 1 hour at 100V. The 
proteins were transferred to a nitrocellulose membrane using the Biorad mini trans-
blot system at 100V for one hour. Protein binding was confirmed via Ponceau 
staining before the membrane was blocked with 5% skimmed milk for 1 hour at 
room temperature. Thereafter the membrane was probed with anti-acetyl histone H4 
rabbit antiserum (recognizing acetylation on K5, 8, 12 and 16), the primary antibody, 
diluted in antibody blocking solution at 4°C over night. On the next day the 
membrane was washed with PBS/Tween and the peroxidase-conjugated secondary 
antibody was applied for 1 hour at room temperature. Finally the bound target 
protein was visualized using ECL (Pierce) reagents following the manufacturer’s 
instructions. 
2.4.5.3 Karyotypic stability 
To ensure that histone hyperacetylation and DNA demethylation do not have an 
adverse effect on karyotypic stability FISH analysis and karyotypic analysis as 
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described in 2.5.3 were carried out with the help of Ms Limbach. At least 20 
metaphases were counted for each condition. 
2.4.5.4 Regional expression profile and neurogenic potential after treatment  
After 72 hours of VPA/AzaC administration as described in 2.4.5.1, total RNA was 
extracted from the cells and analysed for the expression of region-specific markers 
via quantitative PCR. Additionally VPA/AzaC treated cells were differentiated for 
18 days in NGMC medium. After this time they were stained for Tubb3 and GABA 
and their region-specific gene expression was analysed again using quantitative PCR. 
2.4.5.5 Co-culture with VPA/AzaC pre-treated cells 
To test whether hESNSCS are more amenable to primary cell derived patterning cues after 
epigenetic alteration a direct co-culture with cells of E12.5 C57/B6 mice was carried out.  
The primary cells were prepared from forebrain, midbrain and hindbrain as 
described in 2.4.4.2 and mixed in a 1:1 ratio with hESNSCs. The cells were cultured 
for 5 and 9 days, respectively on polyornithine/laminin coated 12-well dishes in 
NGMC medium. 
2.4.5.6 Treatment with BMP4/ RA following VPA/AzaC administration 
To test whether neural precursors are more susceptible to morphogens after DNA 
demethylation and histone hyperacetylation, cells were treated with 3µM RA for 7-10 
days in NGMC medium or 10ng/ml BMP4 for 4 days in N2 medium. At the end of 
the culture periods cells were either fixed in paraformaldehyde for 
immunohistochemical analysis or total RNA was extracted for quantitative PCR 
analysis.  
2.5 Analytical Methods 
2.5.1 Determination of cell number 
Cell viability was determined via trypan blue staining. This diazo dye is not absorbed into 
live cells, but can permeate the membrane of dead cells. Therefore cells with intact membranes 
are not coloured, whereas dead cells show a distinctive blue staining. Since live cells are 
excluded from staining, this method is also called dye exclusion method.   
To determine total cell number, a cell suspension generated via trypsin treatment 
was diluted 1:2 with trypan blue and counted in a Neubauer haemocytometer. 
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2.5.2 Proliferation assay 
5-bromo-2-deoxyuridine (BrdU) is a synthetic analogue of thymidine and can be incorporated 
into the newly synthesised DNA of replicating cells during S phase of cell cycle. It is 
commonly used to detect proliferating cells.  
To quantify the number of cells in the S-phase of cell cycle, hESNSCs were pulsed 
with 10µg/ml BrdU on the first day after passaging for 3 hours. Afterwards they 
were fixed in 4% paraformaldehyde. Simultaneously, hESNSCs were also analysed 
for the expression of Ki67, the prototypic cell cycle related nuclear protein, expressed 
by proliferating cells in all phases of the active cell cycle. It is absent in resting (G0) 
cells (Gerdes  et al. 1991). 
2.5.3 RNA extraction and quantitative RT-PCR analysis 
2.5.3.1 RNA extraction 
All work involving RNA was carried out using RNase free tubes and filter tips. Moreover 
only diethylpyrocarbonate (DEPC) treated water was employed.  
Medium was aspirated and cells were lysed in 100µl Trifast per cm2 of a cell culture 
dish. Complete brain slices and brain sections, on the other hand, were transferred to 
Falcon (15ml) or Eppendorf (1ml) tubes containing 1-2ml Trifast and homogenized 
using the Bandelin Bioplus homogenizer. The lysate of both cells and tissue was 
either stored at -80°C or immediately processed. In both cases a 15-minute incubation 
at room temperature followed the lysing step. Then 200µl chloroform were added 
per ml Trifast, and mixed thoroughly with the lysate. After another 15 minutes of 
incubation the protein, DNA and RNA fractions were separated via centrifugation at 
12000xg/4°C. In the next step the (uppermost) aqueous phase was transferred to a 
new Eppendorf tube and mixed with 1 volume 70% ethanol in DEPC-water. From 
this step onwards the RNeasy kit was employed following the supplier’s instructions 
including DNase treatment. RNA was quantified by optical density measurement on 
the Nanodrop at 260 nm (OD260), where 1 OD260 equals 40µg/ml RNA. The RNA was 
either stored at -80°C or immediately reverse transcribed. 
Since cell numbers following the first FACS experiments were very low, RNA was 
isolated from sorted cells using the PicoPuro RNA Isolation Kit according to the 
manufacturer’s instructions. 
2.5.3.2 Reverse transcription 
For reverse transcription oligo(dT)15 primers were employed to ensure that only mRNA was 
used as template. 
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For each sample 0.8µg total RNA were transcribed into cDNA using the I-script 
cDNA synthesis kit according to the manufacturer’s protocol. As negative control the 
reverse transcriptase was omitted at the cDNA synthesis step once for each sample. 
The cDNA was either stored at -20°C or a (q)PCR reaction was carried out 
immediately following the reverse transcription step. 
2.5.3.3 Design of human-specific primers 
Since the human cells were not separated from the rodent cells at the end of the direct, the re-
aggregation and the slice co-cultures or the in vivo transplantation experiments, human 
specific primers were designed to distinguish between gene expression in human and rodent 
cells.  
For different genes of interest human-specific primers and rodent primers were 
designed in parallel using the Beacon Designer 5 software (Premier Biosoft) allowing 
a species specificity genome blast prior to ordering. The species-specificity of the 
primer pairs was controlled by quantitative RT-PCR using total fetal and adult 
mouse and/or rat brain cDNA and human fetal or adult brain cDNA (Stratagene) as 
positive controls. 
2.5.3.4 Quantitative RT-PCR 
All quantitative RT-PCRs were performed in triplicates on the Biorad Icylcer in 25µl 
reactions. Per reaction 1µl cDNA, 30pmol of each primer, 200µM of each dNTP, 3mM 
MgCl2, 1:2.000.000 SYBR I Green, 10µM Fluorescein and 0.5U Tag-polymerase were 
added. Primer sequences and PCR conditions are listed in 11.6. The specificity of the 
PCR products was confirmed via melt curve analysis and gel electrophoresis. 
In order to compare the expression level of the different genes, all data was 
normalized against the housekeeping gene L27, a ribosomal protein that is expressed 
at a constant level at all times. Threshold cycle, ct, was measured as the cycle number 
at which the SYBR I Green emission increased above a background (threshold) level. 
Specific mRNA transcript levels were calculated using Q-Gene Core Module 1.2 
software (Muller et al. 2002).  
2.5.4 Karyotype analysis  
During long-term cultivation hESNSCs might acquire chromosomal abnormalities. 
Especially gaining a chromosome 12 or 17 leads to a growth advantage for the cells (Draper et 
al. 2004). 
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2.5.4.1 G-Banding 
One day after passaging when the cells had reached 70% confluence medium was 
changed and 0.2µg/ml Colcemid were added for six hours. At the end of this period 
cells were washed twice in PBS, detached from the tissue culture dish via 
trypsin/trypsin inhibitor treatment and spun down. The pellet was cautiously re-
suspended in 1ml 0.075M Potassium chloride (KCL) solution before adding another 
2ml 0.075M KCl-solution and incubating the cell suspension for 10 minutes at 37°C. 
Afterwards three drops of fixative were added and the sample was centrifuged for 10 
minutes at 1500 rpm. The pellet was washed twice more with fixative and finally re-
suspended in 1ml fixative. At this point the samples were either stored at -20°C or 
directly dropped onto degreased microscope slides, which hat been pre-cooled at     
minus 20°C. When the samples had been checked for correct chromosome spreading 
they were incubated over a 60°C water bath for 20 seconds followed by drying on a 
heating plate at 60°C. The samples were incubated at 60°C over night and G-banding 
was performed the next day by Ms Limbach. Briefly, the samples were incubated for 
55 seconds in 2,5µl bactrotrypsin/ml PBS at 37C, rinsed twice in PBS, stained with 
Giemsa-solution for 20 minutes, rinsed, dried, swirled in xylol and mounted in 
corbit. The analysis was carried out at the Institut für Humangenetik of the Medical 
University Bonn at a Leitz Diaplan 68236 microscope using the CytoVision Ultra 
software.  
2.5.4.2 Fluorescence in situ hybridisation (FISH) 
Cells were treated as described in 2.5.3.1. After re-suspension in fixative they were 
dropped onto microscope slides and subsequently Fish analysis was performed by 
Ms Limbach using the Vysis cep12 (32-132012) and cep17 (32-130017) probes 
according to the manufacture’s protocol. 
2.5.5 Agarose gel electrophoresis 
DNA and RNA are negatively charged, due to the phosphate moieties of the sugar-phosphate 
backbone, thus they will migrate towards the positive pole of an electric field. During gel 
electrophoresis DNA (and RNA) fragments are separated according to their molecular weight 
and size, the greater the size of the fragments in any one analysis the lower the agarose 
concentration.  
For separation of DNA on an agarose gel a 1kb (kilo base) marker and/or a 100bp 
(base pair) marker from Peqlab were used. Generally gels consisting of 1% agarose 
and TAE were employed. In the case of detecting fragments following restriction 
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digest with HinF1 3% gels were used. In order to analyse the size of the DNA 
fragments 0,5µg/µl ethidium bromide (EtBr) were added to the gel directly prior to 
pouring. EtBr intercalates between adjacent DNA base pairs and was visualized on a 
transilluminator. Gels were run at 85mV and 200mA for 45 minutes.  
2.5.6 Fluorescence – activated cell sorting  
At the end of the first slice co-culture experiments hESNSCs were separated from the primary 
cells using fluorescence-activated cell sorting. However, considering that the purity of the re-
isolated EGFP-positive cells did not exceed 90%, residual host cells represented a potential 
source for false-positive results in the planned RT-PCR studies. To bypass these problems the 
use of species-specific RT-PCR primers was initiated.  
For re-isolation of transplanted cells lentivirally transduced hESNSCs expressing 
EGFP under control of the phosphoglycerate kinase (PGK) promoter and a 
blasticidine drug resistance gene under control of the SV40 promoter kindly 
provided by Dr. Koch were used. All hESNSCs co-cultured with one brain region 
(e.g. all cells co-cultured with hippocampal slices) were pooled together and digested 
in papain (20 units/ml) for 20 minutes. The digestion was stopped by adding trypsin 
inhibitor solution and the tissue was triturated to a single cell suspension using 
flamed Pasteur pipettes. The mixture was re-suspended at 1-2 million cells/ml in 
FACS buffer containing 0,1% DNAse and all subsequent steps were performed on 
ice. For staining of dead cells 0,5µg/ml propidium iodide were added and the cell 
suspension was passed through a cell sieve. The EGFP-expressing cells were 
collected via flow cytometry using a 70µm ceramic nozzle at a speed of 5000 – 8000 
events per second at the Institute of Molecular Medicine and Experimental 
Immunology, University of Bonn on a fluorescence-activated cell sorter FACS DiVa 
with the kind help of Mrs. Meiners. Viable cells as indicated by propidium iodide 
staining were gated by their forward and side scatter characteristics and gates were 
set to sort EGFP positive cells. Probes were collected in 1.5ml Eppendorf tubes, 
containing 20 units/ml RNAsin and 20µl cell extraction buffer. For quality control 
analysis of the FACS machine a GFP negative cell fraction was always collected in 
parallel. Immediately after sorting the GFP positive cells were frozen on dry ice.   
2.5.7 Immunocytochemistry 
Primary and secondary antibodies as well as the used dilutions, producers of the antibodies 
and peculiarities of the staining are summarized in 11.5. 
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Analysis of immunocytochemical staining was usually carried out on a fluorescence 
microscope (Axioskop2, Zeiss) with the exception of the organotypic slice cultures. 
These were analysed on a confocal laser scanning microscope (Olympus Fluoview 
1000). 
2.5.7.1 Detection of surface markers in cells grown as monolayer 
Cells were fixed in 4% paraformaldehyde for 20 min at room temperature. When 
detecting GABA 0,03% glutaraldehyde were added to the paraformaldehyde. After 
this time the cells were washed twice in PBS, blocked for 30 minutes in blocking 
solution (10% normal goat serum, NGS, in PBS) and incubated with the primary 
antibody in blocking solution overnight at 4°C. On the next day the primary 
antibody was aspirated, cells were washed twice in PBS and the corresponding Cy3 
or FITC conjugated secondary antibody was applied for 1 hour at room temperature 
in order to visualize the antigen. Finally cell nuclei were stained with DAPI (1:10000 
in NaHCO3) and the samples were mounted in Vectashield.  
2.5.7.2 Detection of nuclear markers in cells grown as monolayer 
For the detection of nuclear antigens the cells were fixed for 15 minutes at room 
temperature in 4% paraformaldehyde and subsequently the cell membrane was 
permeabilized via application of 0.5% Triton-X100 in PBS for 15 minutes at room 
temperature. Thereafter the staining continued with the blocking step and was 
carried out as described above (2.5.7.1). 
2.5.7.3 Immunohistochemistry of organotypic slices cultures 
Slices were fixed in 4% paraformaldehyde overnight at 4°C. In the morning they 
were rinsed twice in PBS and then either stored in PBS + sodium azide (0.1%) at 4°C 
or immediately processed. Immunolabelling was performed on free-floating 
specimens in 12-well tissue culture plates, with one slice per well.  After blocking in 
10% fetal calf serum in 0.1% Triton in PBS for at least 6 hours, the primary antibodies 
were applied in blocking solution for 24 hours at room temperature. During this time 
slices were rotated on a shaker at low setting. Afterward the slices were washed in 
PBS + sodium azide for 48 hours before the secondary antibodies were applied in 
blocking solution for approximately 12 hours. Finally the slices were washed again in 
PBS + sodium azide over the course of one day and mounted in Vectashield.  
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2.5.7.4 Immunochistochemistry using tyramide amplification 
Tyramide signal amplification is an enzyme based method utilizing the catalytic activity of 
horseradish peroxidase (HRP) to achieve greatly enhanced (100-fold) labelling of the target 
antigen.  
When using the tyramide amplification system slices were fixed as described above 
(2.5.7.3) and then treated with 0.003% H2O2 for four hours to quench any endogenous 
peroxidase activity. Afterwards the specimens were blocked and stained with rabbit-
anti-human FoxG1 and mouse anti-human nuclei. Subsequently secondary 
antibodies were applied as described above (2.5.6.3). The tyramide enhanced antigen 
was detected using a biotinylated anti-rabbit antibody. In the next step streptavidin 
coupled horseradish peroxidase was applied for 6 hours and finally the tyramide 
development was performed in 0.003% H2O for 35 min.  
2.5.7.5 Detection of BrdU 
The detection of BrdU was accomplished following the method described in 2.5.6.1 
except that after permeabilising the cell membrane also the DNA was denatured via 
incubation in 2N hydroxychloride (HCl) for 10 minutes. Subsequently the HCl was 
neutralized using 0.1 M Borate buffer and the procedure continued with the blocking 
step as described in 2.5.6.1. 
2.5.8 Extraction of total protein  
Medium was aspirated; cells were washed once in ice-cold PBS and PBS containing 
1mM PMSF was applied. In the next step cells were scraped from the dish, 
centrifuged at 1800 rpm/4°C for 10 minutes, resuspended in 50µl lysing buffer per 
well of a 6-well plate (Nunc) and lysed for 1 hour on ice. The lysate was then spun 
down at 12000 rpm for 15 minutes and the supernatant was transferred to a 1.5 ml 
Eppendorf tube. The protein was quantified using the BCA assay kit and frozen at     
-20°C. 
2.5.9 Statistical Analysis 
Unless stated otherwise, errors are given as ± SD and data were analysed using 
students-t test with  p* ≤ 0.05. The quantitative RT-PCR data of the co-cultures was 
analysed using two-way ANOVA (SPSS), following the kind instructions of Mr. 
Mende from the Institut für Medizinische Biometrie, Informatik und Epidemiologie 
(IMBIE) with p* ≤ 0.05 and p* ≤ 0.01. 
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3 Results 
3.1 HESNSCs adopt a specific regional fate under standard culture 
conditions 
As a basis for any meaningful analysis of the hESNSCs regionalization potential the 
ground state of region-specific gene expression was analysed. For the differential 
gene expression analysis several transcription factors were used as candidate 
markers, which are characteristic for specific brain regions (see Table 3). In addition 
also cell type specific markers were tested (Table 4), since some regional transcription 
factors are only expressed in specific cell types. For instance the telencephalic marker 
FoxG1 is expressed in neural precursors and neurons but not in mature glia. Hence if 
FoxG1 expression is investigated the expression of a neuronal marker has to be 
assessed in parallel in order to ascertain whether a change in FoxG1 expression level 
can be explained by a change in the ratio of neurons in the cell population.  
In order to establish a regionalization profile, hESNSCs (H9.2, I3) of passages 3, 14 
and 28 in their proliferative state, i.e. during expansion mediated by the growth 
factors EGF and FGF-2 were tested for region and cell type specific gene expression. 
Additionally, cells from these three passages that had been cultured for 28 days 
without growth factors, i.e. which were differentiated, were also assayed. Total 
human fetal brain RNA at 19 weeks of age obtained from Stratagene was used as 
positive control. While the morphology of the cells was not altered over the passages, 
it was evident from the quantitative RT-PCR data that the regional expression profile 
changed. The hESNSCs showed highest levels of the forebrain markers FoxG1 and 
Dlx1 in the first 9 passages (Fig. 14), but propagation in EGF and FGF resulted in a 
marked down-regulation of the forebrain markers already in passage 14. In cells of 
passage 28 the expression level of the forebrain candidate genes was almost 
undetectable (Fig. 15). This loss of forebrain identity was confirmed by 
immunocytochemical analysis of FoxG1 protein expression (Fig. 16). At the same 
time increased passaging resulted in an up-regulation of the hindbrain markers 
HoxB1 and Gbx2 from undetectable or very low levels to levels 5 fold higher in 
passage 28 compared to passage 3. This up-regulation of hindbrain gene expression 
was already observed in passage 14 and was especially obvious in passage 28 in both 
hESNSC cell lines (Fig. 14, Fig. 15).  
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Fig. 14. Expression of region and cell type specific markers in proliferating and differentiated H9.2 
derived hESNSCs 
Dlx1: ventral forebrain, FoxG1: telencephalon, HoxB1/Gbx2: hindbrain (see schematic overview on 
top), Tubb3: early neurons, Tert.: telomerase, TH: tyrosine hydroxylase – rate limiting enzyme in 
dopamine synthesis, vGlut1: glutamatergic neurons, Gad67: inhibitory interneurons, GFAP: 
astrocytes, CNP: oligodendrocytes, BLBP: radial glia, (P: passage number of hESNSCs used, d: days of 
differentiation, FeB = total human fetal brain cDNA was used as control). All results were normalised 
to L27.  
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Fig. 15. Expression of region and cell type specific markers in proliferating and differentiated I3 
derived hESNSCs 
see Fig. 14 for details 
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In addition to region specific markers cell type specific transcription factors were 
assessed. HESNSCs expressed markers characteristic for neuronal (Tubb3), astrocytic 
(GFAP) and oligodendrocytic (CNP) differentiation in a pattern reflecting 
proliferation or differentiation, e.g. proliferating cells showed less Tubb3 expression 
than differentiated cells of the same passage. The neurogenic potential – i.e. the 
Tubb3 expression level – remained constant over the passages (Fig. 14, Fig. 15). As 
expected Telomerase expression decreased upon differentiation. Moreover 
differentiating neural precursors expressed vGlut1, one of the three known 
glutamate transporters at excitatory synapses, tyrosine hydroxylase, the rate limiting 
enzyme in dopamine synthesis and glutamic acid decarboxylase (GAD), the main 
enzyme in Gamma amino butyric acid (GABA) synthesis, which was used as 
candidate gene for inhibitory interneurons (Watling 1998).  
It has been shown previously that hESNSCs differentiate first into mainly 
GABAergic neurons, then into astrocytes and finally oligodendrocytes started to 
appear in the cultures (Koch et al. 2009). In accordance with these results it was 
found on protein level that hESNSCs in passage 28 which had been differentiated for 
18 days expressed Tubb3 and GABA, the primary inhibitory neurotransmitter of the 
brain. At this time point half of the hESNSCs were Tubb3 positive and of these 53± 
2,9% expressed GABA (Fig. 17).  
Interestingly, expression of the radial glia marker BLBP, which was undetectable in 
passage 3, rose over the passages and during differentiation.  
Taken together these results indicate that during in vitro culture stably proliferating 
hESNSCs loose anterior telencephalic identities as indicated by the loss of FoxG1 and 
seemed regionally biased towards posterior fates compatible with a hindbrain 
location as indicated by the increased expression levels of HoxB1 and Gbx2. This 
Fig. 16. Prolonged passaging reduced the 
number of FoxG1-positive cells 
Neural precursors derived from H9.2 human 
embryonic stem cells showed FoxG1 staining in 
passage six. In passage 14, however, FoxG1 
staining could not be detected anymore (scale bar 
left side 40µm, right side 80µm). 
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shift might be caused by FGF, which is known to alter developmental competence 
and posteriorize neuroepithelial cells (Gabay et al. 2003).  
 
Fig. 17. Differentiating hESNSCs expressed Tubb3 and GABA                                                           
After 18 days of differentiation more than 50% of the hESNSCs (b) had developed into Tubb3 (a) 
positive neurons of which 53± 2,9% were GABAergic (scale bar 50µm). 
3.1.1 Regional gene expression can be influenced via retinoic acid 
application 
After establishing the regional ground state of the neural precursor cells it was 
investigated whether it is possible to change their regional fate using retinoic acid. 
This morphogen was chosen since it plays a crucial role in the specification of the 
vertebrate hindbrain and induces Hox gene expression (Sirbu et al. 2005).  Thus 
neural precursors were treated with RA (5µM) for 14 days. After this time staining 
for HoxB4, which is rarely expressed at the protein level under normal differentiation 
conditions, revealed that 6,4± 0,49% of the RA treated cells and 0,23± 0,11% of the 
control cells expressed the marker. Thus significantly more RA treated cells 
expressed HoxB4 compared to non–treated control cells (Fig. 18). This indicates that 
it is possible to change the regional identity of the hESNSCs using the potent 
morphogen retinoic acid.  
 
Fig. 18. Induction of HoxB4 protein 
expression following RA treatment 
6,4± 0,49% of the neural precursors, 
which have been treated with RA 
(5µM) (a,b,e), showed HoxB4 
expression, whereas control cells 
(c,d,e) only occasionally expressed 
the marker (scale bar 70µm, p* ≤ 
0.05). 
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3.2 HESNSCs are not easily amenable to regional re-specification by 
tissue derived cues 
In addition to posteriorization by RA, parallel studies revealed that the application of 
FGF8 in combination with Shh induced a ventralisation of the hESNSCs (Koch et al. 
2009). These observations suggest that hESNSCs are amenable to regional 
specification by environmental cues. This finding is in accordance with the results of 
several studies suggesting that neural precursor cells originating in a distinct part of 
the neuroepithelium are not restricted to a local fate but are capable of migration and 
differentiation upon heterotopic transplantation, thereby responding to non-cell-
autonomous signals of their new environment, if this new environment provides 
appropriate cues (Renfranz et al. 1991; Brustle et al. 1995; Vicario-Abejon et al. 1995; 
Suhonen et al. 1996; Brustle et al. 1997; Olsson et al. 1998). Therefore it was 
investigated to what extent environmental cues from primary cells and tissues of the 
young rodent brain were capable of influencing the regional transcription factor 
profile of hESNSCs via co-culture. 
To this end paradigmatic co-culture conditions were selected using primary cells of 
different stages of CNS maturation as regional cues are differentially expressed 
during development of the CNS and many are down-regulated as the nervous 
system matures (Zappone et al. 2000). Primary cells from different brain regions are 
known to express distinct regional transcription factor profiles both in vivo and in 
vitro (Ostenfeld et al. 2002; Parmar et al. 2002; Kim et al. 2006).  Changes in regional 
gene expression profile of the hESNSCs were monitored using quantitative RT-PCR 
employing human specific candidate transcription factors. It was assumed that the 
transcription factor expression may be up– or down-regulated depending on the 
primary cell types the neural precursors were co-cultured with. For instance co-
culture with cells of hindbrain origin should result in less expression of the forebrain 
marker FoxG1 than co-culture with cells from the forebrain.  
3.2.1 Shared medium co-culture does not interfere with the intrinsic regional 
expression profile of the hESNSCs 
First a shared medium co-culture setting was chosen to investigate the effect of 
primary cell derived diffusible factors on the hESNSCs.  
In order to do so, 150.000 long term passaged hESNSCs (passage > 28) were plated 
per well of a 6-well tissue culture plate. On the next day primary cells from the 
forebrain, midbrain and hindbrain of newborn (P0) mice were prepared and 200.000 
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primary cells of each region were placed in separate cell culture inserts above the 
neural precursor cells. Through this arrangement the two cell types shared a medium 
throughout the four weeks of co-culture, but were not in direct contact.  
The candidate transcription factor analysis revealed that shared medium culture as 
used in this setting was not sufficient to induce a significant difference in expression 
of regional markers in the hESNSCs. Furthermore no significant change in Tubb3 or 
GFAP expression was observed (Fig. 19). 
 
Fig. 19. Expression of region and cell type specific candidate genes in hESNSCs following shared 
medium co-culture with postnatal day 0 mouse cells  
hESNSCs were co-cultured for four weeks in the same medium as P0 mouse primary cells, but were 
not in direct contact. (a) Independent experiments were performed in triplicates and summarized as 
averages (b). There was no significant induction, due to high variability in expression levels of the 
marker genes corresponding to each of the different brain regions FoxG1 (forebrain), En1 (midbrain), 
HoxA2 (hindbrain) or cell types Tubb3 (young neurons), GFAP (astrocytes). The gene expression 
levels were analysed using two way ANOVA (SPSS). All results were normalized to L27. Data are 
shown as fold expression relative to control treatment, i.e. hESNSCs that were not co-cultured but 
differentiated for the duration of the experiment.  
3.2.2 HESNSCs are not amenable to regionalisation cues from direct co-
cultures with P0 mouse cells 
One possibility why the shared medium co-culture did not induce region-specific 
gene expression could be that specification of regional phenotype is dependent on 
direct cell-cell contact.  Such a finding would be in accordance with the fact that co-
culture settings, which have been shown to be effective e.g. stromal cell-derived 
inducing activity (Kawasaki et al. 2000) rely on direct cell-cell contact. Furthermore it 
is known that cell-cell and cell-matrix contacts such as collagens, proteglycans and 
glyoproteins influence the local microenvironment that elicits the intracellular 
signalling events important in regionalisation (Faissner and Steindler 1995; Olsson et 
al. 1998; Czyz and Wobus 2001). In order to include and use these short range signals 
a co-culture was set up to investigate whether it is necessary for the rodent primary 
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cells to be in direct contact with the hESNSCs in order to exert a regional influence on 
them.  
Primary cells were prepared from the forebrain, midbrain and hindbrain of P0 mice, 
200.000 primary cells of one region e.g. of the forebrain were pooled with 150.000 
long term passaged hESNSCs (passage > 28) in a Falcon tube and the cells of the two 
species were plated together into the well of a 12-well tissue culture plate.  
3.2.2.1 RNA analysis of directly co-cultured cells using species specific primers 
At the end of the co-culture period of 28 days, region and cell type specific gene 
expression was analysed using species-specific primers specially designed for this 
purpose (Fig. 20, Table 4). This ensured that no false positive results were generated 
via the analysis of gene expression of co-cultured primary rodent cells. 
 
 
 
Table 4 List of established and validated human specific primers 
Primer  Expression Domain/ Cell type (MGI database) Approximately expressed in 
mouse brain 
BLBP (Radial) glial cells E11 – adult  
Darpp32 Striatal projection neurons E15 – adult 
DCX Early neurons E11 – E17 
Dlx1 Ventral diencephalon E8 – P12 
Dlx2 Ventral diencephalon E9 – P7 
E2F1 Ubiquitous E9 - adult 
Emx1 Dorsal diencephalon E9,5 – P0 
Emx2 Dorsal diencephalon E8 – P0 
En1 Midbrain E8 – adult 
FoxG1 Dorsal telencephalon E8,5 – adult 
Gad67 Inhibitory interneurons E10,5 – adult 
Gbx2 Hindbrain  E7,5 – P0 
Fig. 20. Design of human-specific primers for qRT-PCR  
Shown are examples of human specific primers used to analyse 
gene expression in the hESNSCs following direct co-culture. 
Lane 1) RT-PCR product with human-specific primers and total 
human fetal brain cDNA; lane 2) same conditions as in lane 1, 
but with a rodent brain cDNA of the appropriate age; lane 3) 
RT-PCR product with species-unspecific primers and with a 
rodent brain cDNA of the appropriate age. 
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List of established and validated human specific primers continued 
Primer  Expression Domain/ Cell type (MGI database) Approximately expressed in 
mouse brain 
GFAP Astrocytes E10 – adult  
HB9  Motoneurons E10,5 – P0 
HoxA2 Anterior hindbrain E8 – Postnatal week 6-8 
HoxB4 Hindbrain E8 – P0 
Krox20 Rhombomeres 3,5; neural crest E8 – P0 
L27 Ribosomal protein E1,5 – adult 
Mash1 Ventral telencephalon/Cerebellum E10 – P7 
Nestin Neural precursors E8,5 – adult 
Nkx2.2 Ventral neural tube E8 – P7 
Otx2 Forebrain  E7,5 – P0 
Pax2 Midbrain E7,5 – adult 
Pax3 Dorsal neural tube E7,5 – adult 
Pax5 Midbrain E8 – P0 
Pax6 Proliferating neurons/ midbrain E6,5 – adult 
Pax7 Dorsal neural tube E10 – P0 
Sox10 Neural crest E8,5 – adult  
Tubb3 Developing neurons E9,5 – adult  
vGlut1 Glutamatergic neurons E18,5 – adult 
vGlut2 Glutamatergic neurons E18, 5 – adult 
3.2.2.2 Gene expression analysis following direct co-culture with P0 mouse cells 
The direct co-culture did not induce a significant region-specific induction of gene 
expression (Fig. 21). There was no significant reduction or induction of FoxG1 or En1 
expression. Additionally the expression levels of Tubb3 and GFAP varied from co-
culture to co-culture with no reproducible trend detectable. However, hESNSCs co-
cultured with P0 midbrain cells expressed repeatedly (Fig. 21a) and significantly (Fig. 
21b) less HoxA2 than cells co-cultured with other brain regions or non co-cultured 
control cells.  Moreover the same cells also expressed repeatedly less En1, but this 
reduction was not significant compared to expression levels of hESNSCs co-cultured 
with hindbrain cells. Nevertheless, this finding differed from the expectation since 
midbrain cells, which themselves express En1 did not induce but down-regulated 
En1 expression in co-cultured hESNSCs.  
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In contrast to the finding, that direct co-culture had little influence on the regional 
candidate marker gene expression in hESNSCs, a study by Roy and co-workers 
showed that direct co-culture had an effect on hES cell derived cells. Specifically it 
was demonstrated that telomerase-immortalized human fetal midbrain astrocytes 
substantially potentated dopaminergic neurogenesis (Roy et al. 2006). One possible 
explanation for this discrepancy is the fact the cells used by Roy and colleagues were 
co-cultured considerably earlier after their derivation from hES cells than the 
hESNSCs. This is an important consideration since the growth factor FGF, which is 
used in to proliferate the hESNSCs under standard culture conditions may alter 
developmental competence of neuroepithelial cells (Gabay et al. 2003). 
Therefore it was investigated in the next step whether short term passaged hESNSCs 
(passage 6) were more responsive to co-culture derived cues of an 28 day direct co-
culture. These hESNSCs were exposed to FGF and EGF for a considerably shorter 
period i.e. at least 22 passages less than the long-term passaged hESNSCs used 
previously. 
However, as seen before the expression level of the representative transcription 
factors was not significantly up– or down-regulated (Fig. 21). On average the co-
cultured hESNSCs showed a down-regulation of all representative candidate 
markers. 
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Fig. 21. Expression of representative regional markers in hESNSCs following direct co-culture with 
postnatal day 0 mouse cells 
200.000 P0 mouse cells of the forebrain, midbrain or hindbrain, were pooled with 150.000 hESNSCs 
and subsequently cultured in a direct co-culture for 4 weeks.  In the first set of experiments long term 
passaged hESNSCs (passage > 28) were used (a,b), whereas in the second set of experiments hESNSCs 
of passage 6 were employed (c,d). Each set of experiments was performed in triplicates (a,c) and 
summarized as averages (b,d). There was no significant induction in hESNSCs of the marker genes 
FoxG1 (forebrain), En1 (midbrain), HoxA2 (hindbrain), Tubb3 (young neurons), GFAP (astrocytes). 
There was, however, a significant reduction in HoxA2 expression in hESNSCs co-cultured with cells 
from the midbrain (b). The co-cultures were analysed using two way ANOVA (SPSS) with p*≤0.05. 
All results were normalized to human specific L27. Data are shown as fold expression relative to 
control cells i.e. hESNSCs that were not co-cultured but differentiated for the duration of the 
experiment. 
3.2.3 Effect of organotypic slice co-culture on regional gene expression of 
hESNSCs 
In parallel with the direct co-cultures an organotypic slice co-culture was set up to 
elucidate whether it is necessary for the primary cells to retain their three-
dimensional structure/position to induce regionalisation of co-cultured neural 
precursors. This model has the advantage that the cell-cell and cell-matrix contacts as 
well as the intracellular signalling events elicited through these contacts, which are 
known to be important in regionalisation (Olsson et al. 1998), more closely resemble 
those in vivo, i.e. the primary cells retain their position within the tissue, which is 
important for their regional identity. 
The challenge of the experimental setup in the organotypic slice co-culture was the 
re-isolation of the co-cultured hESNSCs in a way enabling analysis of gene 
expression via quantitative RT-PCR. 
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3.2.3.1 Re-isolation of hESNSCs after slice co-culture transplantation via FACS 
Organotypic brain slices were prepared from the hippocampus and cerebellum of 9-
day-old Sprague Dawley rats (Fig. 22). Five days after derivation 200.000 EGFP 
positive hESNSCs (> passage 28) were seeded on each slice. In this setting hESNSCs 
typically migrate into the slice tissue where they differentiate (Scheffler et al. 2003). 
 
Fig. 22. Culture on organotypic slices 
Organotypic slices of the cerebellum (a) and hippocampus (b) were prepared from 9-day-old Sprague 
Dawley rats (scale bar size= 2,5mm) and 200.000 hESNSCs were deposited on each slice 5 days after 
derivation. (c) Example of hESNSCs on a hippocampal slice, that was fixed after 21 days of co-culture 
and stained for GFP to detect the transplanted hESNSCs, which expressed EGFP (PCL: pyramidal cell 
layer, scale bar = 200µm) (pictures taken by: bright field Ms Steinfarz, fluorescence Dr. Jakupoglu). 
After 14-21 days FACSorting was used to re-isolate the hESNSCs. To this end all 
engrafted slices of one region were pooled and processed together to a single cell 
suspension. For staining of dead cells 0.5µg/ml propidium iodide were added and 
the cell suspension was passed through a cell sieve. Then the EGFP-expressing cells 
were collected via fluorescence activated cell sorting (FACS). Under optimized 
conditions cell viabilities between 55-95% and sorting efficiencies ranging from 80-
90%  (overview in Table 5) were reached.  
Table 5 Summary of FACSortings following organotypic slice co-culture experiments 
 Experiment I Experiment II Experiment III 
Culture period 14d 18d 21d 
Number of grafted slices Hippo.: 12 Cereb.: 12 
Hippo.: 18 
Cereb.: 17 
Hippo.: 23 
Cereb.:  28 
Total number of 
transplanted hESNSCs 
Hippo.: 1,2 x106 
Cereb.: 1,6 x106 
Hippo.: 1,6 x106 
Cereb.:  2 x106 
Hippo.: 2,3 x106 
Cereb.: 2,8 x106 
GFP positive events 
(automatically counted) 
Hippo.: 66 000 
Cereb.: 80 000 
Hippo.: 190 000 
Cereb.: 130 000 
Hippo.: 450 000 
Cereb.: 225 000 
Percentage of viable cells 
as measured by 
propidium iodide 
exclusion 
55-75% 58-95% 75% 
Sort efficiency (purity 
after sort re-analysis) 80-85% 80-90% 85-90% 
Percentage of GFP + cells 
during FACSorting 5% 1-2% 6-11% 
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However, only 1-11% of the transplanted cell could be re-isolated. Therefore the 
numbers obtained here were not sufficient for extensive subsequent quantitative RT-
PCR analysis. Furthermore, as the purity of the re-isolated EGFP positive cells did 
not exceed 90% residual rodent cells were likely to still represent a potential source 
for false-positive results in the planned qRT-PCR analysis.  
To bypass these problems, in subsequent experiments total RNA was isolated from 2-
3 engrafted slices of the same brain region and species specific primers (3.2.2.1) were 
employed for gene expression analysis. 
3.2.3.2 Transplantation onto slice co-cultures does not regionally specify the 
hESNSCs 
At the end of the slice co-culture period gene expression in transplanted human cells 
was compared to gene expression level of control cells – hESNSCs, that were not 
transplanted, but differentiated on a tissue culture insert for the duration of the 
organotypic slice co-culture. It was found that the anterior marker FoxG1 was 
increased 12,5 fold in hESNSCs transplanted onto hippocampal slices compared to 
neural precursors cultured on cerebellar slices (Fig. 23). This increase in FoxG1 
expression was investigated in more detail, revealing that the telencephalic 
transcription factor was reproducibly and significantly induced between day 6 and 
day 11 of co-culture, with a further significant increase in expression level until day 
15 (Fig. 23d). However, none of the other investigated regional transcription factors 
showed a differential expression pattern in cells transplanted onto hippocampal or 
cerebellar slices. Especially the other employed forebrain marker Otx2 – even though 
it was slightly up-regulated on average – did not mimic the significant induction 
seen in FoxG1 gene expression (Fig. 23a). 
En1 and HoxA2 were both on average down-regulated in transplanted cells 
compared to control cells (Fig. 23a). However, this trend was neither significant nor 
region specific, since hESNSCs transplanted onto both hippocampal and cerebellar 
slices showed decreased En1 and HoxA2 expression compared to control cells. 
Furthermore differentiation of the hESNSCs during the co-culture period had to be 
considered, since FoxG1 is expressed in differentiated neurons but not in 
differentiated astrocytes. Therefore an overall increase in the number of neurons 
generated from hESNSCs transplanted onto hippocampal slices compared to 
cerebellar slices would have led to an overall increase in FoxG1 expression without 
affecting the actual gene expression level. Thus Tubb3 expression was analysed to 
account for the possibility that more neurons might be generated by one of the slice 
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cultures. However, as Tubb3 expression was on average even higher in hESNSCs 
transplanted to cerebellar slices. Thus the significant up-regulation of FoxG1 on 
mRNA level in hESNSCs transplanted to hippocampal slices could not be explained 
by the generation of more neurons in these cultures (Fig. 23a). Hence, it was 
investigated whether the induction of FoxG1 mRNA was mimicked at protein level 
using tyramide-enhanced immunohistochemistry. As shown in Fig. 23b the 
pronounced change in FoxG1 expression observed in the qRT-PCR analysis was not 
adequately reflected at protein level.  
Furthermore the expression of the transcription factor E2F1, which acts as 
transcriptional activator important for progression through G1/S phase transition 
was analysed (DeGregori et al. 1997). Under normal culture conditions E2F1 was 
highly expressed in proliferating neural precursors but down-regulated upon 
differentiation (Fig. 23c). The significant increase in FoxG1 expression in hESNSCs 
transplanted onto hippocampal slices was accompanied by an increase of E2F1 in the 
same cells (Fig. 23a).  
As with the mixed monolayer co-culture in 3.2.2 an organotypic slice co-culture was 
set up also with short-term expanded hESNSCs (passage 3) to study, whether these 
neural precursors keep their forebrain identity when co-cultured on hippocampal 
slices. A different forebrain candidate gene (Dlx1) was used to bypass potential 
differential regulation of FoxG1 at mRNA and protein level. 
However, no significant induction of a representative marker gene was observed 
after transplanting short-term expanded hESNSCs onto organotypic slices. On 
average hESNSCs transplanted to cerebellar slices expressed the forebrain candidate 
gene Dlx1 at higher levels than cells transplanted onto hippocampal slices (Fig. 23e). 
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Fig. 23. Effect of transplanting hESNSCs onto organotypic brain slices on regional gene expression 
in the neural precursor cells 
200.000 long-term expanded hESNSCs were seeded per hippocampal or cerebellar slice. At the end of 
the co-culture period the expression of candidate transcription factors was assessed using the regional 
markers FoxG1/Otx2/Dlx1 (forebrain), En1 (midbrain), HoxA2 (hindbrain), the cell type specific 
marker Tubb3 as well as the cell cycle associated transcription factor E2F1. (a) A reproducible and 
significant induction of FoxG1 and E2F1 expression was found in hESNSCs transplanted onto 
hippocampal slices but not in any other marker gene. The slice co-cultures were analysed using two 
way ANOVA (SPSS) with p**≤ 0.01. All results were normalized to the human specific housekeeping 
gene L27. Data are shown as fold expression relative to control cells, i.e. hESNSCs that were not 
transplanted but differentiated for the duration of the experiment. (b) After 21 days of culture on a 
hippocampal slice hESNSCs (human nuclei: red) show no FoxG1 (FoxG1: green) expression, whereas 
the endogenous cells are clearly immunoreactive (scale bar 50µm). (c) The transcription factor E2F1 
was highly expressed in proliferating neural precursors and down-regulated upon differentiation (P: 
passage number of hESNSCs; d: days of differentiation). (d) FoxG1 expression increased significantly 
between day 6 and day 11 and day 15 of co-culture in hESNSCs transplanted to hippocampal slices. 
(e) The slice co-culture was repeated with hESNSCs of passage 3 using a different forebrain marker 
gene (Dlx1), but no significant induction of a marker gene was found in this setting. 
3.2.4 Embryonic primary cells do not induce region specific gene expression 
in directly co-cultured human neural precursors 
It is known that regional patterning is predominantly taking place during embryonic 
development, whereas in the neonatal brain mainly neurite outgrowth, myelination 
and apoptosis are ongoing (Zappone et al. 2000; Brumwell and Curran 2006). 
Therefore - i.e. to ensure the maximal presence of local patterning cues - an 
embryonic environment was chosen for the next co-culture. 
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In this setting rodent cells were derived from the anterior forebrain and parts of the 
mid- and hindbrain encompassing the midbrain-hindbrain organizer (MHO), a 
region suggested to act as organizer in midbrain/hindbrain development. After 
derivation primary cells were plated at densities of 100.000 cells/cm2 (anterior 
forebrain) and 200.000 cells/cm2 (MHO) respectively. After 7h, when the primary 
cells had begun to settle, the cell debris was washed off and 200.000 long term 
passaged hESNSCs (> passage 28) were added per well and co-cultured for 14-18 
days. 
The gene expression analysis of co-cultured hESNSCs showed that even though En1 
and HoxA2 expression were repeatedly up-regulated in hESNSCs co-cultured with 
the MHO region (Fig. 24a) the overall relative fold change in expression was not 
significant (Fig. 24b). Moreover neither Tubb3 nor GFAP expression were 
significantly changed by the co-culture conditions.  
A direct co-culture with E12.5 primary cells, the earliest cell type amenable to 
preparation, was investigated next. In this setting a slightly different set of candidate 
genes was employed in order to detect regionalising trends, which might have been 
missed using the previous set of marker genes. Otx2 was used instead of FoxG1, 
Pax2 was used in addition to En1 and Gbx2 was used in addition to HoxA2.  
However, overall no significant induction or reduction of region-specific gene 
expression was observed in this co-culture setting (Fig. 24). The forebrain marker 
Otx2 and the midbrain marker Pax2 were up-regulated in all co-cultured cells, 
compared to non co-cultured control cells, while the other midbrain marker En1 was 
on average down-regulated in all co-cultured hESNSCs. 
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Fig. 24. Regional marker gene expression in hESNSCs following direct co-culture with embryonic 
primary cells  
Primary cells were isolated from the E15 (a,b) or E12,5 (c,d) mouse brain and co-cultured in a direct 
setting with hESNSCs. Independent experiments are shown in (a) and (c), and summarized as 
averages in (b) and (d). There was no significant induction in hESNSCs of the marker genes 
corresponding to the brain regions FoxG1/Otx2 (forebrain), En1/Pax2 (midbrain), HoxA2/Gbx2- 
(hindbrain) or cell types Tubb3 (young neurons), GFAP (astrocytes). The co-cultures were analysed 
using two way ANOVA (SPSS). All results were normalized to the expression of the human specific 
L27 primer. Data are shown as fold expression relative to control cells, i.e. hESNSCs that were not co-
cultured but differentiated for the duration of the experiment. 
3.2.5 Effect of re-aggregation co-culture on regional gene expression in 
hESNSCs 
Except for the slice co-culture, where the hESNSCs could invade the slice, the 
previous experiments employed co-culture settings, in which the two cell types were 
mainly cultured as a monolayer. Therefore it was investigated whether the primary 
cells need to surround the hESNSCs – not just grow in direct contact with them – in 
order to induce a change in regional gene expression. To this end a re-aggregation 
co-culture system, where single cell suspensions of freshly primary cells and 
hESNSCs were pooled in a 10:1 ratio in 15ml Falcon tubes and subsequently cultured 
in a roller drum system, was employed (Studer et al. 1998). 
As the hESNSCs exhibited a hindbrain phenotype under standard culture conditions 
and since they did not show region specific adaptation when co-cultured with 
regions remote from this endogenous phenotype, primary cells from the forebrain 
were no longer used for the co-culture. Instead only E12.5 primary cells from the 
Results 
 
 
66 
midbrain and hindbrain were prepared for the co-culture using the midbrain-
hindbrain boundary as anatomical cut-off point to separate the two regions. 
Consequently also the candidate transcription factors employed to assess changes in 
regional gene expression profile were changed. Here the midbrain markers Pax5 and 
En1 in combination with the anterior hindbrain marker HoxA2 were employed. 
To visualize re-aggregation between mouse and human cells, EGFP expressing 
hESNSCs were used. The two cell types aggregated well with each other and 
typically formed one sphere-to-bean shaped structure per Falcon tube (Fig. 25). 
 
 
Fig. 25. Aggregates of primary cells and hESNSCs after 7 days of co-culture  
Typically one aggregate developed per Falcon tube. EGFP expressing hESNSCs aggregated with E12.5 
midbrain cells (a,b) and hindbrain cells (c,d) (scale bar 100µm). 
After 10 days regional gene expression of the human neural precursors was assessed 
using human specific quantitative RT-PCR. Overall there was no significant up- or 
down-regulation of any regional candidate marker in hESNSCs in this co-culture 
model. The midbrain marker En1 was repeatably down-regulated in all re-
aggregated hESNSCs, and the other midbrain marker Pax5 was – though highly 
variable - on average also down-regulated in hESNSCs re-aggregated with midbrain 
primary cells (Fig. 26).  
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Fig. 26. Expression of regional candidate genes in hESNSCs following re-aggregation co-culture 
with mouse E12.5 cells  
Neural precursors were pooled in a 1:10 ration with midbrain or hindbrain primary cells and cultured 
in a roller drum system to achieve aggregation. At the end of the co-culture experiments expression of 
the region specific markers was analysed using human specific quantitative RT-PCR, normalized to 
human specific L27. Independent experiments were performed in triplicates (a) and summarized as 
averages (b) Pax5 /En1 (midbrain), HoxA2 (hindbrain). The data were analysed using two way 
ANOVA (SPSS). Data are shown as fold expression relative to control cells, i.e. hESNSCs that were not 
co-cultured but aggregated for the duration of the experiment. 
3.2.6 Transplantation into different regions of the neonatal rat brain does 
not have a significant influence on the intrinsic regional gene 
expression of hESNSCs 
In a proof-of-principle study it was assessed whether the human specific primers 
could be used to analyse gene expression of hESNSCs transplanted in vivo. In order 
to do so 200.000 hESNSCs were transplanted unilaterally into the forebrain and 
cerebellum of P1 rat pups. After 20 days the animals were sacrificed and total RNA 
was isolated from the forebrain and the cerebellum. Subsequently human specific 
qRT-PCR was performed using this RNA.  
The human specific primers designed in the course of this work were sensitive 
enough to detect gene expression of the transplanted hESNSCs. Although there was 
a trend showing that on average the forebrain markers FoxG1 and Otx2 were 
expressed highest in hESNSCs transplanted to the forebrain, there were no 
significant changes, since the expression levels varied substantially between 
individual samples (Fig. 27). 
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Fig. 27. Expression of candidate genes in neural precursors after in vivo transplantation to P1 rats 
200.000 hESNSCs were transplanted to the forebrain and cerebellum of P1 rats. Gene expression of the 
human cells was analysed after 20 days. Data from the individual samples are shown in (a) and the 
average expression fold changes are shown in (b). Otx2 and FoxG1 expression were markedly but not 
reproducibly or significantly increased in hESNSCs transplanted to the hippocampus. There was no 
detectable FoxG1 expression in hESNSCs transplanted to the cerebellum. Gene expression was 
analysed using two way ANOVA (SPSS). All quantitative RT-PCR results were normalized to human 
specific L27. Data are shown as fold expression relative to control cells, i.e. hESNSCs that were not 
transplanted but differentiated for the duration of the experiment. 
3.3 Effect of DNA methylation and histone hyperacetylation 
One of several explanations for the finding that neither co-culturing with nor 
transplantation into different brain regions induced significant changes in region-
specific gene expression might be that the hESNSCs are not amenable to the 
regionalisation signals of primary cells due to epigenetic mechanisms. Together with 
transcriptional regulators and micro RNAs, epigenetic DNA and chromatin 
alterations play pivotal roles in controlling the plasticity of the transcriptional profile 
of a cell (Chen and Daley 2008). Epigenetic states are somatically heritable and the 
propagation of the specific patterns to the next cell generation is important for 
maintaining cell identity (Avots et al. 2002). Histone acetylation, methylation and 
phosphorylation are among the best know modifications and involved in controlling 
the access of regulatory proteins to specific sequences in the genome (Jenuwein and 
Allis 2001). The level of histone acetylation, which occurs reversibly on lysine e-NH3+ 
groups of core histones depends on opposing activities of histone acetyltransferases 
(HATs) and deacetylases (HDACs). For the latter enzyme family several specific 
inhibitors are known for instance trichostatin A (TSA; Yoshida et al. 1990) and 
valproic acid (2-propylpentanoic acid, VPA). VPA is a well-tolerated anticonvulsant 
inhibiting both class I and II HDACs resulting in hyperacetylation of histone H3 and 
H4 (Kramer et al. 2003). Acetylation of histones H3 and H4 is associated with active 
transcription (Jenuwein and Allis 2001).  
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A second epigenetic modification of the vertebrate genome is methylation of cytosine 
within CpG dinucleotides leading to a stable repression of transcription (Bird 2002).   
While in adult somatic cells DNA methylation patterns are stable, they are very 
dynamic during early development (Schmutte and Jones 1998). AzaC is often used as 
a DNA methylation inhibitor. When incorporated into DNA, it covalently binds to 
and irreversibly blocks the maintenance methyltransferase Dnmt1, allowing passive 
demethylation to take place as cells divide (Pietrobono et al. 2002).  
It is known that the developmental potential of ES cells can be in part ascribed to 
their dynamic epigenetic state. Thus it was tested whether treating the hESNSCs with 
the HDAC inhibitor VPA and the nucleotide analogue AzaC alters their 
developmental competence.  
3.3.1 Treatment with VPA and AzaC results in histone hyperacetylation and 
DNA demethylation  
It has been reported that VPA at a concentration of 1mM inhibits HDAC in adult rat 
hippocampal neural progenitors (Hsieh et al. 2004). Therefore it was tested in the 
first step whether administration of the standard concentration of 1mM would result 
in hyperacetylation in the hESNSCs. This was assessed through detecting changes in 
histone acetylation using Western blot analysis with an antibody specific for 
acetylated histone 4. The outcome suggested that under normal culture conditions 
treatment with 1mM VPA for 3 days greatly enhanced acetylation on histone 4 in 
hESNSCs (Fig. 28a). 
In the next step it was studied, whether the second agent – AzaC – caused DNA 
demethylation in the hESNSCs at concentrations of 250nM and 500nM (Schmittwolf 
et al. 2005). Neural precursors were cultured under standard culture conditions for 3 
days with or without the addition of AzaC. For detecting changes in methylation 
pattern the method of Yang and co-workers was used. In this approach global DNA 
methylation was determined via employing bisulfite treatment of DNA, followed by 
non-specific PCR amplification of long interspersed nucleotide elements (LINEs), 
which are usually heavily methylated.  Finally restriction enzyme digest of the PCR 
product was performed using HinF1.  This endonuclease only cuts repetitive 
elements that were originally methylated because the cytosine residues of the 
enzyme recognition site in the unmethylated repetitive elements were converted into 
uracil during the bisulfite reaction. As expected HinF1 generated digestion products 
of 285bp, 247bp, 166bp and 128bp when using control DNA, that was not AzaC 
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treated (Yang et al. 2004). In Fig. 28b the lower bands represent methylated repetitive 
elements. The upper band represents unmethylated repetitive elements.  
 
Fig. 28. VPA/AzaC treated hESNSCs were demethylated and hyperacetylated 
(a) Cells had been treated with 1mM VPA for 72h. Histone acetylation status was investigated using 
an anti-acetyl-H4 antibody. (b) Genomic DNA was treated with sodium bisulfite and a non-specific 
PCR was performed, which amplified a pool of LINE-1 repetitive elements. The PCR product was 
digested with HinFI, which only cuts repetitive elements that were originally methylated. The 
digested PCR product was separated by agarose gel electrophoresis and stained with Ethidium 
bromide. The lower bands (285bp, 247bp, 166bp and 128bp) represent methylated repetitive elements, 
suggesting that the untreated cells were methylated (lane 1). The upper band (413bp) represents 
unmethylated repetitive elements, indicating that the treated cells were demethylated (lanes 2/3). 
The untreated neural precursors were methylated (lanes 1) whereas the treated cells 
were demethylated (Fig. 28, lanes 2 and 3). 
3.3.2 VPA/AzaC treatment does not affect karyotypic stability, proliferation 
rate or regional gene expression in hESNSCs 
In the preliminary experiments of 3.3.1. 250nM AzaC were sufficient to induce 
demethylation. Since it has been suggested that AzaC may induce chromosomal 
abnormalities at high concentrations (3µM) the low dose of 300nM AzaC was chosen 
for subsequent experiments (Harrison et al. 1983). After 72h of 1mM VPA and 300nM 
AzaC administration the morphology of treated hESNSCs was undistinguishable 
from control cells  (Fig. 29). 
 
FISH analysis was carried out on chromosomes 12 and 17q, since hES cells are 
susceptible to anaploidy of these chromosomes leading to increased proliferation and 
hence a selective advantage (Draper et al. 2004). FISH analysis of the hotspots on 
chromosomes 12 and 17q as well as G-banding (at least 20 metaphases were counted 
Fig. 29. Morphology after VPA/AzaC 
treatment (I3 P30) 
After 72 h of VPA/AzaC administration 
treated cells (b) were indistinguishable 
from control cells (a). Scale bar 30µm. 
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for each condition) demonstrated that 72h of VPA/AzaC administration did not 
cause an increase in chromosomal abnormalities compared to control cells (Fig. 30). 
 
Fig. 30. Treatment with 1mM VPA and 300nM AzaC did not cause an increase in chromosomal 
abnormalities as measured by FISH analysis and G-banding 
Control hESNSCs (a,d) were cultured under standard conditions for three days, while treated neural 
precursors (b,e) received a daily dose of 1mM VPA and 300nM AzaC. (a,b,c) The results of the FISH 
analysis for chromosomes 12 and 17q as well as (d,e) G-banding suggested that this treatment regime 
did not have adverse effects on chromosome numbers compared to control cells.  
Additionally the treatment with VPA and AzaC did not change proliferation rate (as 
determined by BrdU incorporation and Ki67 staining, Fig. 31) and 72h of VPA (1mM) 
and AzaC (300nM) administration did not change the expression levels of regional 
and cell type specific marker genes (Fig. 32a). 
 
Fig. 31. Treatment with 1mM VPA and 300nM AzaC for 72h did not significantly affect the 
proliferation rate of hESNSCs.  
Shown are the averages of three independent experiments, in which proliferation rate was analysed 
via BRDU incorporation (a,c,d) and Ki67 expression (b,e,f), respectively. Scale bar 15µm. 
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In order to investigate potential long-term effects of VPA/AzaC treatment, 1mM 
VPA and 300nM AzaC were administered to proliferating hESNSCs for 72h. 
Subsequently the neural precursors were differentiated for 18 days.  At the end of 
this period gene expression levels of cell type specific markers (Tubb3, Gad67, 
vGlut1) as well as regional specific markers (Otx2, Pax3, HoxA2) were compared to 
expression levels in control cells, which were not treated with VPA or AzaC prior to 
differentiation. The findings of these analyses suggested that on mRNA level pre-
treatment resulted in a slight but significant decrease of Tubb3 expression (Fig. 32b). 
The expression level of the other candidate genes was statistically unaltered after 18 
days of differentiation (Fig. 32b). The decrease in Tubb3 expression on mRNA level 
was not confirmed on the protein level (Fig. 32 e,f).  50, 2 ±4,9%  of the control cells 
and 48,3 ±4,3% of the pre-treated hESNSCs differentiated into Tubb3 positive 
neurons. Of these Tubb3 positive neurons 53,7 ±2,4% and 51,7 ±3,3% were GABA 
positive in control and pretreated cells, respectively (Fig. 32c-f).  
 
Fig. 32. Expression of region and cell type specific markers after 72h of VPA/AzaC treatment and 
subsequent differentiation of pre-treated hESNSCs for 18 days 
(a) hESNSCs treated with 1mM VPA/300nM AzaC for 72h did not show a significant alteration in the 
expression of candidate genes compared to non-treated control cells. (b) Pretreated hESNSCs 
differentiated for 18 days showed a significant decrease in Tubb3 expression.  No significant changes 
in regional (Otx2, Pax3, HoxA2) or other cell type specific (Gad67, vGlut1) gene expression were 
observed. (c,e) After differentiation for 18 days 50.2± 4,9%  of the control cells expressed Tubb3 and of 
these cells 53,7± 2,4% were GABA positive. Of the pretreated cells 48± 4,3% had differentiated into 
Tubb3 positive neurons (d,f). Of these 51.7± 3.3% were GABA positive. All gene expression data were 
normalized to L27 and analyzed using students t-test, p*≤0.05. Data are shown as fold expression 
relative to control cells, i.e. hESNSCs, which were proliferating or differentiated under standard 
conditions but not treated with VPA or AzaC (Scale bar 30µm) 
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3.3.3 Pre-treatment with VPA and AzaC does not render the hESNSCs more 
susceptible to co-culture derived environmental cues 
The previous results showed that there was no significant difference in regional gene 
expression and differentiation behaviour between VPA/AzaC pre-treated and non-
pretreated control cells. To test whether demethylation and simultaneous 
hyperacetylation render the hESNSCs more susceptible to regionalisation cues of 
primary cells, co-cultures with hESNSCs, which had been pre-treated for 72h were 
set up. To this end long term passaged hESNSCs (> passage 28) were treated with 
1mM VPA and 300nM AzaC for 72h. After this time freshly prepared primary cells 
from the forebrain, midbrain-hindbrain organizer region and spinal cord of E12.5 
mice were added to the hESNSCs. The cells were not actively mixed, because the 
human neural precursors showed very limited tolerance to trypsin treatment, 
following VPA/AzaC administration. In this setting also a spinal cord preparation 
was included to analyse whether it might be possible to further posteriorize the 
hESNSCs. 
As demonstrated in Fig. 33a/b after 5 days of direct co-culture no significant 
difference in gene expression levels was detectable in the co-cultured hESNSCs. 
Therefore the exposure time of the hESNSCs to the primary cells was increased to 9 
days of co-culture. In this setting slightly different candidate genes were employed. 
Pax2 was used instead of En1 and Gbx2 was used instead of HoxA2. The rationale 
for choosing transcription factors, which are specific for slightly different regions in 
the midbrain and hindbrain, was that it might be possible to pick up regionalizing 
trends, which were overlooked using the previous set of marker genes. Due to 
limited amounts of RNA it was not possible to analyse all transcription factors 
simultaneously.  
However, also with this set of candidate markers no significant induction of gene 
expression in VPA/AzaC pretreated cells was detected after 9 days of co-culture 
(Fig. 33c/d). Gene expression of both co-culture settings was also compared to gene 
expression of non-treated non-co-cultured cells (data not shown), but no differential 
induction of gene expression was observed. 
These findings suggest that VPA/AzaC treatment did not substantially increase the 
responsiveness of hESNSCs to primary cell derived cues. 
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Fig. 33. Expression level of candidate markers genes in hESNSCs, which were pre-treated with 
VPA and AzaC and subsequently co-cultured with different regions of the embryonic mouse brain.  
hESNSCs were treated with 1mM VPA and 300nM AzaC for 72h. After this time freshly prepared 
primary cells from the forebrain, MHO region and spinal cord of E12.5 mice were added. The two cell 
types were co-cultured for 5 (a,b) or 9 days (c,d). There was no significant induction of the marker 
genes corresponding to each of the different brain regions FoxG1/Otx2 (forebrain), En1/Pax2 
(midbrain), HoxA2/Gbx2 (hindbrain). The co-cultures were analysed using two way ANOVA (SPSS). 
All results were normalized to human specific L27. Data are shown as fold expression relative to 
control cells, i.e. hESNSCs, which were pre-treated but non co-cultured. 
3.3.4 VPA/AzaC treatment enhances the response to morphogens 
From previous experiments it was known that the neural precursors respond to high 
levels of single morphogens (3.3.1,(Koch et al. 2009). Therefore it was investigated 
whether demethylation and simultaneous hyperacetylation render the hESNSCs 
more susceptible to regionalisation cues of defined morphogens.  
In order to do so cells, which had been treated with VPA and AzaC for 72h as 
described above, were cultured for an additional 7-10 days in the presence of 3µM 
retinoic acid. RA is involved in posteriorization and induction of Hox gene 
expression during normal embryogenesis (Maden et al. 1998). At the end of the 
culture period induction of hindbrain genes was assessed via immunohistochemical 
staining of HoxB4 (Fig. 34) as well as quantitative RT-PCR of HoxB4 and additional 
hindbrain genes (HoxB8, HoxD11). 30,7± 4% of the VPA/AzaC pre-treated cells 
expressed HoxB4 on protein level compared to 3,9± 1,7% of control cells. Thus the 
treated cells showed significantly increased HoxB4 protein expression after RA 
application suggesting that they were more posteriorized than control cells (Fig. 34 
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a,b,c). This observation was confirmed via quantitative PCR (Fig. 34d), which also 
detected a significant induction of the additional hindbrain genes HoxB8 (3,7 fold 
increase)  and HoxD11 (6 fold increase)  as well as a down regulation of the forebrain 
gene Otx2 (1,6 fold decrease).  
 
Fig. 34. Increased responsiveness of hESNSCs to RA following pre-treatment with VPA/AzaC  
After treatment with 1mM VPA/300nM AzaC for 72h hESNSCs were subsequently cultured in the 
presence of 3µM RA for an additional 7-10 days. 3,9±1,7% of control cells (a,b) and 30,7±4 of pre-
treated hESNSCs showed HoxB4 protein expression (a,c). This significant increase was confirmed by 
quantitative PCR data (d) demonstrating a significant induction of further hindbrain genes as well as 
a down-regulation of Otx2. Data were analysed using student’s t-test, with p*≤0.05, Data are shown as 
fold expression relative to control cells, i.e. hESNSCs, which were not treated with VPA/AzaC but 
treated with RA (scale bar 10µm). 
These results suggest that demethylation and hyperacetylation render neural 
precursors more responsive to potent morphogens. In order to further substantiate 
this notion, the effect of the increased responsiveness mediated by pre-treatment 
with VPA/AzaC had to be translated from the anterior-posterior axis to the dorso-
ventral axis. For this purpose the morphogen BMP4 was chosen, which is involved in 
dorsalization of the spinal cord during development (Liu and Niswander 2005). The 
hypothesis was that if VPA/AzaC treatment increased the responsiveness of the 
neural precursors to morphogens this treatment scheme should result in a 
dorsalization, i.e. an increased Pax3 expression in the hESNSCs.  As demonstrated in 
Fig. 35 BMP4 administration to VPA/AzaC treated neural precursors resulted in an 
significant induction of Pax3 expression on protein level from 0,8± 0,7% in control 
hESNSCs (Fig. 35a/b) to 5,5± 1,2% in pre-treated hESNSCs (Fig. 35a/c) as well as a 
significant increase of Pax3 on mRNA level (4,3 fold), thereby indicating a 
dorsalization of the hESNSCs. The up-regulation of the dorsal marker Pax3 on 
mRNA level was accompanied by a significant down-regulation of the ventral 
marker Nkx2.2 ( 2 fold decrease) (Fig. 35d). 
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Fig. 35. Increased responsiveness of hESNSCs to BMP4 following pre-treatment with VPA/AzaC  
Following administration of 1mM VPA/ 300nM AzaC for 72h neural precursors were subsequently 
cultured in the presence of 10ng/ml BMP4 for 4 days. The control cells (a,b) no application of 
VPA/AzaC, but administration of BMP4 showed only occasional expression of the dorsal marker 
Pax3. HESNSCs, which had been pretreated, however, showed a significant increase of Pax3 protein 
expression (a,c). This finding was confirmed by quantitative PCR data (d) demonstrating a significant 
induction of Pax3 as well as a down-regulation of the ventral marker Nkx2.2. Data were analysed 
using student’s t-test, with p*≤0.05, Data are shown as fold expression relative to control cells, i.e. 
hESNSCs, which were not treated with VPA/AzaC but treated with BMP4 (scale bar 20µm). 
These observations substantiate the notion that pre-treatment with VPA and AzaC, 
i.e. DNA demethylation and histone hyperacetylation, renders the hESNSCs more 
responsive to the effect of potent morphogens.  
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4 Discussion 
All major somatic cell lineages can be generated from human embryonic stem cells. 
Several studies have demonstrated the capacity of embryonic stem cells to generate a 
variety of neural subtypes including motoneurons and dopaminergic neurons (Bain 
et al. 1995; Okabe et al. 1996; Li et al. 1998; Kawasaki et al. 2000; Tropepe et al. 2001; 
Yang et al. 2008).  
However, until now grafted cells often show insufficient differentiation, a process 
very likely controlled by correct region-specific gene expression and indispensable 
for functional improvement (Kim et al. 2003). Therefore research is focused on the 
challenge of generating neural populations with a defined region-specific phenotype. 
Here multipotent, stable proliferating, long-term expandable human embryonic stem 
cell derived neural stem cells were chosen as a model system. Under standard 
culture conditions these neural precursors show a defined regional gene expression 
profile, which corresponds to a hindbrain identity. This defined regional phenotype 
provides an ideal starting point for detecting minimal changes of regional 
transcription factor expression. Therefore the hESNSCs were chosen for 
systematically studying whether primary cell derived cues are capable of influencing 
the regional phenotype of neural precursor cells. 
4.1 Neural precursors maintain their neurogenic potential and 
posteriorize during prolonged expansion in the presence of growth 
factors  
In contrast to other embryonic stem cell derived neural precursors the hESNSCs 
showed robust neuronal differentiation over the passages as demonstrated by Tubb3 
expression in quantitative RT-PCR (Fig. 15) as well as immunocytochemistry (Fig. 17) 
(Elkabetz et al. 2008). They did not acquire a gliogenic bias upon prolonged 
passaging (Koch et al. 2009). This was an important observation as neural 
stem/progenitor cell expansion was until recently accompanied by a diminished 
potential to generate neurons over glial cells (Tropepe et al. 2001). In mES cell 
derived neural stem cells this bias was only resolved in 2005, when it was shown that 
they could be expanded for over 100 passages and still retain the capability to 
produce large proportions of neurons (Conti et al. 2005).   
In order to further characterize the hESNSCs, it was investigated whether the 
regional gene expression changes. Both I3 and H9.2 derived hESNSCs showed a 
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distinct pattern of region-specific gene expression. In early passages the cells 
displayed high expression levels of the representative forebrain markers FoxG1 and 
Dlx1 (Fig. 14, Fig. 15). During prolonged proliferation using EGF and FGF these 
anterior markers were down-regulated. Simultaneously the expression of the 
posterior markers HoxB1 and Gbx2 increased (Fig. 14, Fig. 15). From at least passage 
10 onwards the neural precursors displayed a defined hindbrain phenotype (Koch et 
al. 2009). This phenotype was maintained during prolonged in vitro culture.  
The original acquisition of an anterior phenotype was reminiscent of earlier 
observations in both mouse and human ES cells.  It was found by several groups that 
ES cells derived neural cells adopt anterior CNS characteristics by default (Wichterle 
et al. 2002; Li et al. 2005; Watanabe et al. 2005). The finding that the hESNSCs first 
expressed anterior markers is in accordance with the anterior neural default model 
postulated in classical studies of Xenopus CNS development.  These studies detected 
that during development the neuroectoderm at the head region forms first and is 
then shifted towards posterior fates in response to secreted signals including RA, 
FGFs and Wnts (Nieuwkoop 1952; Sasai and De Robertis 1997).  At present 
prolonged proliferation of NSC and neural progenitors in vitro – including our own 
protocol – relies on the presence of FGF. FGF family members possess a broad 
mitogenic potential. They signal via receptor tyrosine kinases resulting in the 
activation of the Ras/MAP kinase signalling pathway (Jaye et al. 1992; Kouhara et al. 
1997; Eswarakumar et al. 2005). Specifically FGF2 is known to alter developmental 
competence and posteriorize neuroepithelial cells (Gabay et al. 2003; Hack et al. 2004; 
Zhang 2006). Possibly due to the almost universal employment of FGF for 
proliferation, no protocol for stably proliferating forebrain precursors has been 
published yet. Since in humans the forebrain is the largest part of the CNS, 
derivation of such a protocol is a major goal, as it would allow the generation of the 
rich array of neuronal subtypes that are present in the forebrain. One of currently 
most promising approaches to generate forebrain fates is via inhibiting endogenous 
Wnt signals, which are also implicated in anterior-posterior specification. For mouse 
ES cells Watanabe and co-workers have demonstrated that this strategy increased the 
level of neural progenitors displaying forebrain characteristics by 30% (Watanabe et 
al. 2005).  
Recently, also a different type of hES cell derived neural stem cells has been reported. 
These cells, generated from the early rosette stage of neural stem cell development 
(conclusively termed R-NSCs), showed broad differentiation potential toward CNS 
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and PNS fates as well as in vivo engraftment. Just like the early rosette stage cells of 
which they are derived, R-NSCs exhibited robust FoxG1 expression.  Elkabetz and 
co-workers hypothesized that this conservation of forebrain fate is due to 
supplementation with SHH and the Notch agonists DLL4 and Jagged-1. It was 
demonstrated that in the absence of SHH and Notch pathway activation the R-NSCs 
progressed to a more restricted – i.e. less patternable – NSC stage, probably 
comparable to the hESNSCs. Despite this Notch pathway activation, the R-NSCs 
cannot be maintained in long-term in vitro culture (Elkabetz et al. 2008).  
Hence it seems as if neural stem cells expressing forebrain marker genes and 
displaying a broad differentiation potential can be proliferated via Notch pathway 
activation for a limited period of time (up to 4 passages) (Elkabetz et al. 2008), but in 
order to achieve long-term in vitro cultivation, protocols not relying on FGF still need 
to be developed. 
4.2 Neural precursors remain amenable to patterning by retinoic acid  
Treatment of mouse embryonic stem cells or embryonic carcinoma cells with RA has 
been the most commonly used approach for neural differentiation due to its 
simplicity and high efficiency (Jones-Villeneuve et al. 1982; Bain et al. 1996). In 
contrast, if neural fate is already determined RA instead acts mainly to posteriorize 
neural cells. This was observed first in Xenopus and then also in mouse embryos. If 
the embryos were treated with excess RA, anterior structures were lost, whereas the 
hindbrain and spinal cord seemed to expand. At the same time anterior genes such 
as Otx2, Emx1 and Dlx1 were repressed and posterior genes such as Krox20 and 
various Hox genes were up-regulated (Agarwal and Sato 1993; Avantaggiato et al. 
1996; Maden 2002; Sirbu et al. 2005).  
To test whether the hESNSCs are amenable to change in regional gene expression 
when treated with morphogens, retinoic acid was chosen. The treated cells showed 
significantly increased expression of the hindbrain gene HoxB4 (Fig. 18). These data 
suggest that neural precursors possess the potential for directed region specific 
differentiation in vitro when treated with RA. 
Data from parallel studies performed by Koch et al. suggested that the hESNSCs 
were amenable to alterations in regional gene expression when treated with FGF8 
and Shh ((Koch et al. 2009). This is a well-established combination of morphogens 
resulting in neural progenitors with mid/hindbrain characteristics and subsequent 
specification of dopaminergic neurons (Zhang 2006).  
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Other groups obtained comparable results. Bouhon and co-workers reported that 
they could progressively posteriorize their mouse embryonic stem cell derived 
neural progenitors. When treated with FGF2 and RA the cells down-regulated Pax6 
and up-regulated midbrain and hindbrain markers including En1 and HoxB4 
(Bouhon et al. 2006). Furthermore Pankratz and colleagues have recently reported a 
similar observation in human embryonic stem cells (Pankratz et al. 2007). Their 
primitive neuroepithelial cells initially exhibited an anterior identity as judged by 
widespread Otx2 expression. It was possible to transform this anterior phenotype via 
retinoic acid administration to a more posterior fate. Treatment with RA for 8 days 
resulted in most cells expressing the hindbrain marker HoxB4 and only a few cells 
maintaining Otx2 expression. In this context it should be noted that the cells used by 
Pankratz and co-workers were analysed four weeks after initial differentiation from 
hES cells. This was a time point considerably earlier than that at which our stable 
neural precursor population was assayed (Pankratz et al. 2007).  Importantly, other 
findings indicated that mouse and human ES cell derived neural progenitors lost 
their responsiveness to single morphogens after in vitro cultivation (Bouhon et al. 
2006; Elkabetz et al. 2008). For example in the above mentioned study Bouhon and 
co-workers observed that they could induce motoneuron formation from their mouse 
embryonic stem cell derived neural progenitors between day 4 and 8 but not 
anymore between day 16 and 20 of differentiation (Bouhon et al. 2006). 
Thus the hESNSCs, in contrast to other ES cell derived neural precursors, appear to 
retain their responsiveness to single morphogens even after prolonged in vitro 
expansion.  
4.3 Tissue derived cues are not sufficient to induce and consolidate 
regional re-specification in hESNSCs 
In principle, it should be possible to generate specific subtypes of neurons and glia 
by adjusting the concentration of morphogens or combination of morphogens. This 
was successfully accomplished in the case of progenitors from different sub-regions 
of the spinal cord, which were induced to form motoneurons via application of RA 
or FGFs and GDF11 (Wichterle et al. 2002; Li et al. 2005). Yet, many morphogens are 
expressed at different locations and varying time-points during CNS development. 
Consequently additional factors such as timing, space and quantity of patterning 
cues or other molecular events are necessary to produce distinct neural subtypes 
(Zhang 2006). One possibility to address this complex interaction is to model the 
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specific regional environment of representative brain regions in vitro using acutely 
isolated primary cells. Employing this approach it was studied systematically to 
which extent cues from primary cells of different brain regions are capable of 
influencing region-specific gene expression of hESNSCs using paradigmatic co-
culture settings. 
This approach seemed feasible, as earlier studies suggested that mES derived neural 
precursors were capable of migration and differentiation upon transplantation into 
the embryonic rat brain displaying extensive axonal innervation of the host brain. 
These results indicate that in vitro derived neural progenitors are capable of 
responding to signals of their new environment (Brustle et al. 1997). 
Moreover it has been demonstrated that cues from co-culture paradigms can induce 
region specific marker gene expression in neural stem cells. Specifically it was 
reported that co-culture with E14.5 mouse ventral forebrain tissue induced 
expression of an early onset ventral forebrain specific reporter gene in neural stem 
cells from the dorsal forebrain as well as from the midbrain/hindbrain. This was 
possible even though the stem cells from the different regions expressed distinct 
regional identities in vitro prior to co-culture (Hitoshi et al. 2002). 
These different results suggest that tissue derived cues may influence both primary 
neural stem cells and ES cell derived neural progenitors. 
Diffusible primary cell derived cues are not sufficient to induce changes in regional gene 
expression in hESNSCs 
In the first instance a shared medium co-culture setting was chosen to investigate, 
whether diffusible factors released by primary cells were sufficient to induce regional 
specification of hESNSCs. Of special interest was the question whether long term 
passaged hESNSCs (> passage 28), which displayed a hindbrain phenotype prior to 
co-culture, could be reverted to a forebrain fate. Thus it was investigated whether 
expression of forebrain transcription factors could be induced (again).  
The results (Fig. 19) suggested that the shared medium co-culture did not induce any 
significant and reproducible changes in the expression of representative transcription 
factors corresponding to the distinct brain regions, i.e. no effect of the co-culture on 
region specific gene expression was evident.  
 
Some examples of co-culture settings that were applied successfully by other groups 
include telomerase-immortalized fetal midbrain astrocytes that enriched for human 
embryonic stem cell derived dopaminergic neurons (Roy et al. 2006, 2007). Moreover 
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astrocytic co-culture was shown to accelerate the onset of synaptic activity (Johnson 
et al. 2007) and stromal cell-derived inducing activity is known to promote 
differentiation of neural cells from mouse embryonic stem cells (Kawasaki et al. 
2000). Even though these approaches are dependent on a range of different effects 
they all use direct cell-cell contact. Therefore a direct co-culture model was set up 
next.  
Direct co-culture derived cues do not induce regional re-specification 
Also the direct co-culture of hESNSCs with P0 mouse cells did not result in a 
significant induction of regional gene expression corresponding to the employed 
brain regions (Fig. 21). In contrast, hESNSCs co-cultured with the forebrain showed 
on average the highest expression of the hindbrain marker HoxA2 of all co-cultured 
cells.  
One explanation for this finding could be that human embryonic stem cell derived 
neural cells, which – in contrast to our hESNSCs – have been shown to be amenable 
to co-culture mediated effects were tested considerably earlier after their derivation 
from hES cells than the cells used in this study. Johnson and colleagues started their 
co-culture using astrocytes at three weeks of hES cell differentiation, while Vazin et 
al. employed stromal co-culture directly from the start of their differentiation 
protocol (Johnson et al. 2007; Vazin et al. 2008). Thus the hESNSCs used in this study 
were proliferated substantially in vitro, whereas cells used by other groups in 
comparable experiments were not.  
In our setting employing cells earlier after derivation from hES cells would be 
problematic. It would be difficult to judge how much of any occurring change in 
regional phenotype was due to long-term proliferation using FGF and how much to 
co-culture derived cues.  
Despite these considerations a direct co-culture using short-term passaged hESNSCs 
(passage 3-6) was conducted. The reason were reports (study by Bouhon and 
colleagues see above) suggesting that with increasing passage number embryonic 
stem cell derived neural precursors loose their responsiveness to local inductive cues 
(Bouhon et al. 2006). In addition to the number of divisions the time of differentiation 
might be impacting on the ability of neural precursors to respond to patterning 
signals. For example Li et al. claimed that the capacity of human embryonic stem cell 
derived neural progenitors to generate region specific neurons is progressively 
restricted (Li et al. 2005). They observed that HB9, characteristically expressed in 
motoneurons, could be effectively induced via treatment with RA and Shh in early 
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neural precursors 10 days after differentiation from hES cells but not in late neural 
precursors 15 days after initial differentiation. Thus it seemed as if the cells had lost 
their responsiveness to the patterning cues in just 4-5 days. This notion corresponds 
to findings in primary neural stem cells, which were shown to respond differently to 
extrinsic cues at different stages of cortical development. It was observed that E12 
mouse cortical precursors do not respond to CNTF/LIF administration. In contrast, 
in adult CNS stem cells CNTF/LIF treatment resulted in astrocytic differentiation 
(Molne et al. 2000). 
However, the outcome of our experiment showed that the expression level of the 
candidate transcription factors was not significantly up- or down-regulated in 
hESNSCs of passage 6 in three independent experiments (Fig. 21). This suggests that 
the passage number of the hESNSCs was not the main reason for the lack of 
induction of region specific gene expression in the direct co-cultures. 
To maximise the presence of patterning factors two direct co-culture models 
employing embryonic day 15 and 12.5 primary cells, one of the earliest cell types 
amenable to preparation, were studied. Yet, gene expression analysis following co-
culture with both embryonic cell types revealed no region-specific induction of gene 
expression (Fig. 24). 
 
Isolated induction of the regional transcription factor FoxG1 in slice co-cultures 
To explore whether the primary cells need to maintain their three-dimensional 
position to induce regionalisation a slice co-culture model was investigated. This 
setting has the advantage that the cell-cell and cell matrix contacts such as collagens, 
proteoglycans and glycoproteins more closely resemble the in vivo situation (Faissner 
and Steindler 1995). An example for the potency of extra cellular matrix components 
is the suggestion by Cyzy and Wobus that interaction of embryonic stem cells with 
the extra cellular matrix via integrins determines the expression of signalling 
molecules BMP-4 and Wnt-1. This activation is important for mesodermal and 
neuroectodermal lineage induction (Czyz and Wobus 2001).  
Differences between brain regions also seem to be reflected in the adhesive 
properties of the primary cells.  Specifically, it was reported that regional differences 
in neuronal differentiation were reflected by differential expression of Ca2+ 
independent CAMs (Whitesides and LaMantia 1995). Thus in a slice co-culture, 
where hESNSCs are surrounded by local cues and gradients of patterning factors 
might arise, extra cellular matrix components might have an influence on co-cultured 
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hESNSCs. In contrast, in a monolayer co-culture, primary cells might release 
patterning cues, which then simply drift off into the medium.  Another property of in 
vivo arealization is mirrored more closely in a three-dimensional setting than in a 
direct co-culture. This is the fact that neural progenitors encounter multiple 
competitive instructive signals from all sides at any one time (Anderson 2001). 
 
The slice co-culture model significantly increased expression of the forebrain gene 
FoxG1 in hESNSCs transplanted onto the hippocampus (Fig. 23). Since the 
hippocampus itself expresses FoxG1, this might indicate a region specific marker 
gene induction. Moreover, it suggested a possible reversal of the hindbrain 
phenotype. Yet, none of the other regional transcription factors were differentially 
regulated. Particularly, the other employed forebrain marker Otx2 did not mirror the 
significant induction of FoxG1 in hESNSCs co-cultured on hippocampal slices. 
Furthermore the anterior hindbrain marker HoxA2 was not down-regulated in cells 
transplanted to hippocampal slices compared to those transplanted to cerebellar 
slices. This, however, would be expected if there was ongoing regional specification. 
Finally the FoxG1 induction was not reflected at protein level (Fig. 23).  
The significant robust increase of FoxG1 expression at the RNA level argues against a 
random induction of the gene. Nevertheless, considering that none of the other 
transcription factors was significantly induced or reduced and that FoxG1 expression 
was not increased at protein level, it became unlikely that the induction of FoxG1 on 
mRNA level was due to a regionalizing effect of the slice co-culture.  
Interestingly, it has been reported that FoxG1 up-regulation is associated with 
increased proliferation of neural precursors (Martynoga et al. 2005). Such an 
interpretation would be compatible with the observed significant induction of E2F1 
on mRNA level in hESNSCs transplanted to hippocampal slices. E2F1 is a factor 
acting as transcriptional activator important for progression through G1/S phase 
transition (DeGregori et al. 1997). To further address this issue a detailed 
proliferation analysis including BrdU-pulse experiments would be required. 
Re-aggregation co-culture does not suffice for induction of region-specific gene expression in 
hESNSCs 
The three-dimensional slice co-culture, where the hESNSCs can invade the slice and 
acquire a three-dimensional position within the regionally specified primary cells, 
had yielded a significant induction of the marker gene FoxG1. Thus the influence of a 
re-aggregation co-culture, where the hESNSCs are also surrounded by primary cells, 
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on the regional gene expression of the hESNSCs was tested. The advantage of the re-
aggregation co-culture, where primary cells and hESNSCs were cultured in a roller 
drum system (Studer et al. 1998), was that embryonic primary cells could be used 
thereby maximising the presence of patterning factors. Usually one sphere per Falcon 
tube developed. In this sphere hESNSCs were evenly distributed among the primary 
cells. Therefore the conditions for maximal interaction between primary cells and 
hESNSCs were provided. However, the long term expanded human neural 
precursors did not show region specific gene induction in this model.  This outcome 
was surprising since the setting was in our opinion the most powerful one, because 
the co-cultured cells completely intermingled with each other and the MHO alone is 
necessary and sufficient for induction of mesencephalic and metencephalic structures 
(Marin and Puelles 1994).  
hESNSCs remain insensitive to regionalisation cues of the intact neonatal brain 
Finally in vivo transplantation was used to assess the power of the generated and 
validated human-specific primers established in the course of this project. To this 
end hESNSCs were transplanted into the forebrain and cerebellum of P1 rat pups. 
After 21 days regional marker gene expression was analysed via quantitative RT-
PCR. While the gene expression of the hESNSCs could be analysed using the human 
specific primers, transplantation into the intact neonatal brain did not induce 
significant changes in region-specific gene expression (Fig. 27).  
 
There are several explanations, which could account for the fact the primary cell 
derived cues were not sufficient to influence the regional gene expression of the 
hESNSCs.  
First of all, the variability in the quantitative PCR results might have been too high to 
detect significant, reproducible changes in gene expression level.  One reason for the 
high variability between individual experiments might be the primer design. Since 
the primers had to be human specific in order to distinguish between gene 
expression in primary cells and hESNSCs, only a restricted choice of primer 
sequences was available. Therefore primer selection was limited. For instance it was 
not always possible to generate a primer pair with melting temperatures within 1°C 
of each other.  The variability in gene expression level between individual 
experiments could also be a result of subtle differences in the primary cell 
populations used for the co-cultures. Even though the derivation procedure was 
standardized such subtle differences cannot be completely ruled out.   
Discussion 
 
 
86 
Furthermore only rodent tissue was available for the co-cultures. This tissue might 
not have been able to exert the same influence on human cells given their longer 
maturation time and differing molecular signature as human tissue might have been 
able to do. An indication that human cells can influence human cells in a co-culture 
setting was published by Roy and co-workers. Their immortalized mesencephalic 
astrocytes of human origin were shown to drive development of dopaminergic 
neurons from hES cells (Roy et al. 2006). In the same study hES derived cells were 
treated with the patterning factors Shh and FGF8 and co-cultured simultaneously 
(Roy et al. 2006), whereas the hESNSCs were only co-cultured. Therefore it could be 
tried to supplement our co-cultures with defined morphogens.  
Besides it has been hypothesized that cells might have to undergo their final division 
in their new environment to respond appropriately to local cues (Brustle et al. 1995). 
A potential avenue to further investigate this possibility would be to normalize the 
candidate gene expression in a co-culture experiment to those hESNSCs that divided 
again using a BrdU-pulse experiment. Furthermore it might be possible that long-
term proliferation using FGF does not only compromise positional identity (Hack et 
al. 2004), but also compromises the ability to respond to tissue derived patterning 
cues. Even hESNSCs of passage 3, the youngest passage used for experiments in this 
study, might already have a restricted capacity for region specific differentiation. As 
discussed above Li et al. published that human ES cell derived neural progenitors 
respond effectively to directed posteriorization 10 days after derivation from hES 
cells. However, already 4-5 days later the neural progenitors had lost their 
responsiveness to RA and Shh (Li et al. 2005). The mechanisms that cause this limited 
temporal responsiveness to patterning cues are unknown. However, it has been 
suggested that temporal responsiveness is a mainly intrinsic property (Allen 2008), 
possibly related to epigenetic events. 
 
4.4 DNA demethylation and histone hyperacetylation enhance the 
response of neural precursors to defined morphogens  
The lack of response of the hESNSCs to primary cell derived regional stimuli after 
long-term in vitro propagation might also be a result of their non-permissive 
epigenetic organisation. As stated above alterations in histone acetylation and DNA 
methylation patterns are fundamental for establishing and maintaining cell type 
specific gene expression patterns (Jaenisch and Bird 2003). To change these 
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consolidated gene expression patterns the DNA in the hESNSCs was demethylated 
via AzaC treatment and histones were hyperacetylated using VPA administration.  
VPA, a widely employed antiepileptic drug and antimanic mood stabilizer, has been 
reported to inhibit histone deacetylase, to modulate GABA levels in the brain, to 
activate the ERK pathway and to induce ERK pathway mediated neurotropic actions 
(Biggs et al. 1994; Bowden et al. 1994; Gottlicher et al. 2001; Phiel et al. 2001; Hao et al. 
2004). In our setting administration of 1mM VPA caused HDAC inhibition and thus 
histone hyperacetylation. To account for any possible influence of VPA on GABA 
expression in the predominantly GABAergic neural precursors (Fig. 17) 
immunohistochemical analysis was performed. No effect on the ratio of detected 
GABA positive neurons could be found (Fig. 32). 
Moreover, it was necessary to investigate whether VPA via modulation of the ERK-
signalling pathway had any effect on neural differentiation or proliferation.  
It was found that DNA demethylation and histone hyperacetylation did not cause 
significant alterations in proliferation rate or regional expression profile in the 
hESNSCs. Treatment with VPA and AzaC resulted in significantly less Tubb3 
expression on mRNA level compared to non-treated control cells. This observation is 
in contrast to previous findings. For example inhibition of HDAC activity using VPA 
was claimed to result in neuronal differentiation of adult hippocampal neural 
progenitors. This effect was attributed to VPA inducing neurogenic transcription 
factors including the basic helix-loop-helix factor NeuroD, thereby promoting 
neuronal fates and inhibiting glial differentiation (Hsieh et al. 2004).  Another study 
reported that HDAC inhibition significantly stimulated neuronal lineage progression 
in E14 mouse neural stem cell differentiation. In the employed minimal serum-free 
culture medium HDAC inhibition promoted the development of normal 
electrophysiological recordings and correct morphological maturation 
(Balasubramaniyan et al. 2006). The differing results might be ascribed to the fact that 
the hESNSCs were embryonic stem cell derived and not acutely isolated from 
rodents.  
After administration of 1mM VPA and 300nM AzaC for 72h hESNSCs were 
subsequently treated with 3µM RA. This treatment scheme resulted in a significantly 
increased expression of the hindbrain gene HoxB4 on both protein and mRNA level 
(Fig. 34). Previous experiments had already shown that RA alone is sufficient to 
posteriorize the hESNSCs (3.1.1). Now, these experiments indicated that 
posteriorization via RA application following pre-treatment with VPA and AzaC is 
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approximately 9 times as potent as RA application alone. Simultaneously with 
HoxB4 also HoxB8 and HoxD11, two additional hindbrain genes, were significantly 
up-regulated and expression of the forebrain marker Otx2 was down-regulated. 
Furthermore, after pre-treatment with VPA and AzaC and subsequent 
administration of 10ng BMP4 the hESNSCs exhibited a significantly increased 
expression of the dorsal marker Pax3. At the same time levels of the ventral marker 
Nkx2.2 decreased. Taken together these results suggest that DNA demethylation and 
histone hyperacetylation enhance the effect of the defined morphogens RA 
(posteriorization) and BMP4 (dorsalization) on the hESNSCs. 
Nevertheless, treatment with VPA and AzaC did not increase the responsiveness of 
the neural precursors to co-culture derived regionalisation cues.  This is surprising 
since Schmittwolf and co-workers have reported that following DNA demethylation 
and histone hyperacetylation, neurospheres contributed to chimeric haematopoietic 
systems after transplantation into irradiated adult recipients (Schmittwolf et al. 2005). 
Hence these demethylated and hyperacetylated neurospheres showed a 
destabilisation of cell lineage commitment. This finding is also in agreement with the 
observation that histone deacetylase inhibitors and DNA demethylation increase the 
efficiency of reprogramming (Kishigami et al. 2006; Rybouchkin et al. 2006). 
Especially, it was claimed recently that VPA improves reprogramming efficiency by 
more than 100-fold. As a consequence it was possible to generate iPS cells without 
using the oncogene c-Myc (Huangfu et al. 2008). 
A possible explanation for the apparent discrepancy regarding the potency of VPA 
treatment in our setting is the fact that epigenetic modifications do not alter the 
complete transcriptome. On the contrary, only 3% of all genes were influenced by 
DNA methylation and histone hyperacetylation in one report (Van Lint et al. 1996). 
In further experiments it could be elucidated whether treatment with VPA/AzaC 
during the co-culture period renders the hESNSCs more susceptible to primary cell 
derived cues. However, in such a setting the primary cells themselves could loose 
their regional identity upon exposure to VPA and AzaC.  
Moreover the lack of responsiveness of the hESNSCs might be attributed to the co-
culture conditions themselves: if they do not sufficiently mimic in vivo conditions 
(dilution of patterning cues etc. see 4.3) rendering the cells more responsive to 
regionalising cues will be in vain.  
Nevertheless, this study suggests in accordance with others (Ruau et al. 2008) that by 
modifying the epigenetic state of precursor cells one can extend their developmental 
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capacity. In our case this might open the possibility to generate region specific neural 
precursors under controlled conditions that can be readily manipulated. 
In summary the observations of this work suggest that hESNSCs retain a 
responsiveness to high levels of defined morphogens, which is enhanced by DNA 
demethylation and histone hyperacetylation, but are not easily amenable to regional 
specification by tissue derived environmental cues. These results support the notion 
that region specific gene expression is not easily overcome by tissue derived 
instructive factors in vitro. 
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5 Perspectives 
The studies described here represent the first systematic investigation of the 
influence of tissue-derived cues on the regional gene expression of hESNSCs. The 
results suggest several approaches for further pursuing the objective of elucidating 
methods for the generation of neuronal subtypes expressing distinct regional 
transcription factor profiles similar to those observed in the CNS in vivo. 
For instance, the finding that histone hyperacetylation and DNA methylation seem to 
lead to an increased responsiveness to defined morphogens could be used to increase 
the effectiveness of existing protocols employing morphogens. For instance it would 
be interesting to investigate whether the efficiency of procedures already leading to a 
specific neuronal population expressing a distinct neurotransmitter as well as 
regional transcription factor profile is enhanced if the cells are subjected to DNA 
demethylation and histone hyperacetylation. The generation of motoneurons using 
Shh and retinoic acid would be an excellent target for such an experiment (Li et al. 
2005) 
Further studies could also address whether the combination of epigenetic alteration 
and tissue derived environmental cues can be utilized to induce regional 
specification in human ES cell derived neural precursor cells in vivo. To this end 
VPA/AzaC pre-treated hESNSCs could be transplanted into neonatal rodents. After 
a sufficient period of time their regional gene expression could be analysed using 
quantitative RT-PCR as well as immunohistochemical analysis.  
An interesting question would be to investigate in detail whether the presence of 
both VPA and AzaC is required to induce an increased responsiveness to defined 
morphogens.  
Moreover elucidating exactly which transcription factors are affected directly by the 
treatment with VPA and AzaC might identify regulatory genes involved in 
patterning the CNS. This could be achieved using a CHIP-based method thereby 
moving from the candidate gene approach of this work to a more global gene 
analysis. 
Overall the likelihood of pluripotent cell derived neural precursors to be used in 
regenerative medicine is increasing with the growing knowledge about their 
characteristics, their potential, and their limits. The finding that the susceptibility of 
hESNSCs to patterning by morphogens seems enhanced after DNA demethylation 
and histone hyperacetylation might lead to more protocols providing region specific 
neural cells for use in future cell replacement therapies. 
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However, it should be noted that the results of a number of previous studies implied 
that neural and even non-neural cells can be easily recruited into a region specific 
fate (Flax et al. 1998; Brazelton et al. 2000; Mezey et al. 2000; Munoz-Elias et al. 2004; 
Bae et al. 2007). Although care has to be taken to extrapolate our findings to other cell 
populations, the results of this study should serve as a note of caution, since the 
findings suggest that neural precursors are not easily recruited into a specific 
regional phenotype by tissue derived cues but need to be specified to a high extent, 
before envisaging future region-specific cell replacement strategies.  
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6 Abstract 
The derivation of region-specific neural cells from human embryonic stem cells holds 
great promise for future cell replacement strategies of neurodegenerative diseases. 
However, the possibility to recreate the diversity of the mature CNS with its 
numerous types of neurons displaying distinct region-specific transcription factor 
expression profiles in vitro using defined morphogens seems limited. Therefore this 
study sought to investigate whether primary cells from different regions of the 
developing rodent brain – which themselves are known to be regionally specified – 
can influence the regional identity of human ES cell-derived neural stem cells 
(hESNSCs). 
After establishing the regional gene expression profile of the hESNSCs under 
standard culture conditions in vitro the cells were exposed to paradigmatic co-culture 
settings. To that end cells from forebrain, midbrain, hindbrain/cerebellum and spinal 
cord of embryonic and P0 mice as well as hippocampal and cerebellar slices of 9-day-
old rats were used. To analyse the gene expression of co-cultured human cells 
human-specific real time RT-PCR primers were designed and implemented. 
Surprisingly, neither co-culturing with nor transplantation onto or even in vivo 
transplantation into different brain regions induced significant changes in region-
specific gene expression in the hESNSCs. 
As it is known that the developmental potential of ES cells can be in part ascribed to 
their dynamic epigenetic state it was subsequently tested whether subjecting the 
hESNSCs to DNA demethylation and histone hyperacetylation would alter their 
developmental competence. Remarkably, even modifying the epigenetic state did not 
suffice to increase the responsiveness of hESNSCs to primary cell derived cues. 
However, administration of VPA and AzaC seemed capable of intensifying the effect 
of defined morphogens such as retinoic acid and BMP4 to posteriorize and dorsalize 
the hESNSCs, respectively.  
These observations suggest that hESNSCs retain a responsiveness to high levels of 
single morphogens but are not easily amenable to regional specification by tissue 
derived environmental cues even after DNA demethylation and histone 
hyperacetylation.  
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7 Zusammenfassung 
Die Herstellung von regional-spezifischen neuralen Vorläuferzellen aus 
embryonalen Stammzellen ist eine viel versprechende Möglichkeit zur Gewinnung 
von Zellen für Zellersatztherapien neurodegenerativer Erkrankungen.  Allerdings ist 
es unwahrscheinlich, dass es in vitro gelingt das hochkomplexe Zentralnervensystem 
mit seinen vielen verschieden neuronalen Phänotypen, die unterschiedliche regional 
Transkriptionsfaktoren exprimieren, mit Hilfe von Morphogenen nachzubilden. Das 
Ziel dieser Arbeit war daher eine systematische Untersuchung der Frage, ob 
Primärzellen aus definierten Gehirnregionen, die selbst ein regionalspezifisches 
Genexpressionsmuster aufweisen, neurale Vorläufer (hESNSCs) so beeinflussen 
können, dass diese eine regional-spezifische Differenzierung und damit eine 
Adaptation an ihre Umgebung zeigen.  
Nachdem das regionale Genexpressionsmuster der hESNSCs unter 
Standardkulturbedingungen ermittelt worden war, wurden paradigmatische 
Kokulturexperimente durchgeführt.  Für die Kokulturen wurden Zellen aus dem 
Vorderhirn, dem Mittelhirn, dem Hinterhirn/Cerebellum und dem Rückenmark von 
embryonalen und P0 Mäusen sowie hippocampale und cerebellare Schnittkulturen 
von 9 Tage alten Ratten verwendet. Um die Genexpression von kokultivierten 
hESNSCs analysieren zu können, wurden humanspezifische RT-PCR Primer 
entworfen und implementiert.  
Überraschenderweise konnte in keiner der untersuchten Ko- bzw. Schnittkulturen 
eine signifikante Veränderung der regionalen Genexpression humaner neuraler 
Vorläuferzellen festgestellt werden.   
Da bekannt ist, dass das Entwicklungspotential von ES Zellen teilweise auf ihren 
dynamischen epigenetischen Zustand zurückzuführen ist, sollte im zweiten Teil der 
Arbeit geklärt werden, ob die Plastizität neuraler Vorläufer hinsichtlich ihres 
regionalen Phänotyps durch Histonhyperazetylierung und DNA-Demethylierung 
zunimmt. Bemerkenswerterweise schien auch eine Modifizierung dieser Prozesse 
nicht auszureichen, um die Empfänglichkeit der hESNSCs für die 
regionalspezifischen Einflüsse der Primärzellen zu steigern. Allerdings schien die 
Behandlung mit VPA und AzaC zu einer Verstärkung der Effekte der definierten 
Morphogene Retinsäure  (Posteriorisierung) und BMP4 (Dorsalisierung) zu führen. 
Daher wird davon ausgegangen, dass hESNSCs die Fähigkeit besitzen, auf hohe 
Dosen definierter Morphogene zu reagieren, aber selbst nach DNA-Demethylierung 
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und Histonhyperazetylierung nicht einfach durch regionale Stimuli aus ihrer 
Umgebung regionalisierbar sind. 
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11 Appendix 
11.1 Consumables 
Consumables Manufacturer 
15cm cell culture dishes TPP 
1ml injection needles BD Bioscience 
8-stripes for quantitative RT-PCR  Biozym 
Cell sieve (40 µm) BD Bioscience 
Cryovials Nunc 
Cuvettes Eppendorf 
Disposable Pipettes  (1ml, 2ml, 5ml, 10ml, 25ml) Falcon 
Disposable Pipettetips (10µl, 100µl, 200µl, 1000µl) ART 
Falcon-tubes Falcon, Heidelberg 
Filter (0,2µm) Nalgene 
Gauge-needles Microlance 3 BD Bioscience 
Microscope slide Menzel 
Reaction vessels Eppendorf 
Stericup-filters  (0,22µm) Millipore 
T175 flask  BD Falcon 
Vitrics Schott, Mainz 
12 well tissue culture plates  BD Bioscience 
6 well tissue culture plates Nunc 
 
11.2 Equipment 
Appliance Name/Manufacturer 
Bühler shaker  EB KS-15 Control, Johanna Otto GmbH  
Centrifuges Megafuge 1.OR, Heraeus Instruments  
Eppendorf Centrifuge 5415 C, Eppendorf  
RC5B Plus, Sorvall Heraeus Instruments  
Cleanbench (horizontal)  HERAguard Thermo Electron 
Cleanbench (vertical)  Holten Safe 2000 Thermo Electron 
Confocal laser scanning Microscpe Mikroskop Fluoview1000 Olympus 
Cryostat HM 560                                                             Microm Laborgeräte GmbH   
Digital Camera C 5050 Zoom Olympus Optical 
Electrophoresis  Agagel Mini Biometra, Göttingen 
FACS DiVa Becton Dickinson 
Freezing unit Cryo 1°C Freezing Container Nalgene 
Gel documentation Geldoc2000 Bio-Rad, München 
Heated plate OTS40 Medite, Burgdorf 
Heating unit                                                           UNITEK HB-130/E  
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Homogenizer Bandelin Plus 
Hybridisiation oven OV3                                                      Biometra  
Incubator                                                                                   Heracell, Heraeus Instruments  
Incubator HERAcell Thermo Electron, Waltham 
Laminar-Air-flow workbench Herasafe, Heraeus Instruments  
Microscopes Axiovert 25, Zeiss  
Axiovert 135, Zeiss  
Axioskop 2, Zeiss  
Leica  
LSM-510, Zeiss  
Neubauer cell counting camber Roth  
pH-electrode CG840 Schott  
Photometer Biophotometer Eppendorf 
Nanodrop ND-1000, Fisher Scientific 
Pipettes 10µl, 100µl, 200µl, 1000µl Eppendorf 
Pipetting aid Pipetboy Brand, Faust 
Quantitative PCR Cycler iCycler Bio-Rad 
Scales Precision Balance LA310S Sartorius 
Thermocycler T3 Biometra 
Thermomixer Compact Eppendorf 
Ultrasound bath Bandelin Sonorex 
Vacuumpump BVC21 + BVC01 Vacuubrand GmbH und Co  
Vortex  Genie 2 Scientific Industries 
Water bath 1008, GFL  
 
11.3 Chemicals, solutions, enzymes 
Substance Manufacturer 
1kb plus DNA ladder Invitrogen 
2-Mercaptoethanol  Invitrogen 
30% acrylamide mix Biorad 
6x DNA loading buffer Fermentas 
Acetic acid Merck 
Agarose PeqGold Universal PeqLab, 
APS Sigma 
B27 Gibco 
Bactotrypsin BD Bioscience 
Bromphenol blue Sigma 
BSA Sigma 
Chloroform  Sigma 
Colcemid  Invitrogen 
Cyclic AMP Sigma 
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Cytocoon buffer Evotec  
DAPI  Sigma 
DMEM  Invitrogen 
DMEM/F12 Invitrogen 
DMSO  Sigma 
DNase  Sigma 
dNTP Peqlab 
Dulbecco’s Phosphate Buffered Saline Invitrogen 
EDTA Roth 
EGF R&D Systems 
Ethanol  Merck 
Ethidiumbromide Sigma 
FCS Invitrogen 
FGF-2  Invitrogen 
Fibronectin MP Biomedicals 
Ficole Sigma 
Fluorescein  Sigma 
Gelatine Typ A  Sigma 
Glucose Sigma 
Glutaraldehyde  Sigma 
Glycin Sigma 
Gycerol Sigma 
HinF1 Invitrogen 
Insulin Sigma 
Isopropanol  Sigma 
Knockout-DMEM  Invitrogen 
Knockout-Serum Replacement  Invitrogen 
Kollagenase Typ IV  Invitrogen 
L-Glutamine Invitrogen 
Ligase Invitrogen 
Lipofectamine 2000 Invitrogen 
Magnesiumchloride  Invitrogen 
Matrigel  BD Bioscience 
Methanol  Carl Roth 
Mowiol  Sigma 
NaN3 Sigma 
Neurobasal medium Gibco 
Non-essential amino acids Invitrogen, Metabion 
Oligo-(dt)-Primer Invitrogen 
Papain Sigma 
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Paraformaldehyde Sigma 
Potassiumchloride Sigma, 
RNAsin Promega  
SDS Roth 
Skimmed milk powder Roth 
Sodiumselenite Sigma 
Sodiumacetate Sigma 
Sodiumhydrogencarbonate Sigma 
Sodiumpyruvate Invitrogen 
Sucrose Roth 
SYBR Green I  Sigma 
Taq-Polymerase  Invitrogen 
TEMED Sigma 
Tissue Tek  Sakura 
Transferrin Sigma-Alrich 
Trifast Peqlab 
Tris-HCl  ICN Biomedicals 
Triton-X100  Sigma 
Trypan-Blau  Invitrogen 
Trypsin-EDTA (10x)  Invitrogen 
Tween 20 Sigma 
Vectashield Vector laboratories 
Xylene Cyanole Biorad 
 
11.4 Kits 
BCA Assay  Pierce 
DNase Kit Qiagen 
DNeasy Blood and Tissue Kit  Qiagen 
EpiTect Bisulfite Kit Qiagen 
Iscipt Kit Biorad 
Peqlab Cycle Pure Kit  Peqlab 
PicoPuro RNA Isolation Kit Arcturus 
RNeasy Kit Qiagen 
Super Signal West Femto Kit  Pierce 
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11.5 Antibodies 
11.5.1 Primary Antibodies 
Antigen Description  Dilution Type  Pre-treatment Producer 
BrdU 1:33 ms HCl Sigma 
BrdU 
Uridin-Derivative which can 
incoporate into the DNA instead 
of thymidine  1:200 rat HCl BD 
GABA Gamma-amino-butyric acid; 
inhibitory neurotransmitter of 
the  CNS 
1:300 rat Triton –X 100 DSHB, Iowa 
City  
FoxG1 Regional transcription factor 
expressed in the telecenphalon 
1:5000 rb Triton –X 100 Kind gift of 
Dr. Studer 
Nkx2.2 Nkx2.2 is a member of the 
mammalian NK2 homeobox 
transcription factor family that 
is expressed in the ventral CNS 
and the pancreas 
1:300 ms Triton –X 100 DSHB, Iowa 
City 
GFAP 1:1000 rb  Dako 
Cytomation 
GFAP 
Glial fibrillary acidic protein; 
intermediate filament in 
astrocytes  1:100 ms  ICN 
GFP 1:3000 rb Triton –X 100 Abcam 
GFP 
Green fluorescent protein 
1:700 ms Triton –X 100 Chemicon 
HoxB4 Homeodomain protein 
expressed in the hindbrain and 
spinal cord 
1:10 rat Triton –X 100 DSHB, Iowa 
City 
Nestin Intermediate filament 1:100 ms Triton –X 100 RD&Systems 
Pax3  Paired box 3 gene, expressed 
during early to midgestation in 
the dorsal neural tube  
1:250 ms Triton –X 100 DSHB, Iowa 
City 
S100β Calcium-binding protein 
expressed by glial cells of the 
CNS and PNS  
1:2000 ms  Sigma 
Tuj1 1:1000 ms  Covance 
Tuj1 
Beta-III tubulin 
1:1000 rb  Covance 
 
11.5.2 Secondary Antibodies 
Conjugate Type  Dilution Producer 
Cy3 Goat anti-mouse IgM IgG 1:300 Jackson Immuno Research  
Cy3 Goat anti-rabbit  IgG 1:300 Jackson Immuno Research  
FITC Goat anti-rabbit  IgG 1:200 Jackson Immuno Research 
FITC Goat anti-mouse IgM IgG 1:250 Jackson Immuno Research 
Biotin Anti-rabbit 1:200  Dako  
Streptavidin coupled 
HRP 
Anti-rabbit 1:500 Dako 
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11.6 Primers 
If not stated otherwise quantitative RT-PCRs were run for 38 cycles and at 3mM MgCl. 
 
11.6.1 Human specific quantitative RT-PCR primers  
Primer  Sequence (5’-3’) Annealing 
temp. 
Product 
melting temp.  
 
Product 
length 
BLBP CGACCTACTCCGCTAACC 
CTCCAGTGTCCCTCTTTCC 
63 87  119 
Darpp32 CTTTGGCTGATACCCAGAGAACC 
GAGTAGAATTGTGAAGGGCAAATCC 
62 91 181 
DCX CCGCACTATCTACACCATC 
TCACAGAGGAGGCAGCAG 
62 90 190 
Dlx1 AGACAGCCCAAGCAGCAAGATAAAC 
AATGAGGACAGCGGACGGATGAG 
65 89 198 
Dlx2 AGATTTTCCCACTGATTTATTTG 
CAACAACAAAGACTTTAGGATAC 
64 89 194 
E2F1 GCAGAGCAGATGGTTATGGTG 
TATGGTGGCAGAGTCAGTGG 
62 92 218 
Emx1 AGTCCGAGCAGAAGAAGAAGG 
CAGCAGCAAGCAGCACTC 
64 91 146 
Emx2 TCCTCAACGGCTTCCACTC 
TCGGCGAACACCAAGTCC 
63 91 78 
En1 GGCTATCCTACTTATGGGCTCAG 
CTTCTCGTTCTTCTTCTTCTTCAG 
64 93 160 
FoxG1 CCCTCCCATTTCTGTACGTTT 
CTGGCGGCTCTTAGAGAT 
65 86 203 
Gad67 GATCTGCTTCCGGCTAAGAACGGTG 
AAGTGTTATTTGTTCCATGAGGACA 
63 94 386 
Gbx2 TGGAGAGCGATGTGGACTAC 
CCTGTCTTGGAATTGGCATTG 
62 89 342 
GFAP ATCAACTCACCGCCAACAGCGCC 
CTCATACTGCGTGCGGATCTCTT 
63 92 346 
HB9  GTTACTCATCCATTGCCATC 
CCAGGTTGCTACAAGAGG 
62 88 199 
HoxA2 GAACTGCTTACACCAACAC 
TTCCTCGTCCTCCTCTAC 
63 89 253 
HoxB4 TTTCATCTTTAATCACGCCAGGTC 
GAAAGGAAATCCAGGCTGTCTTC 
62 93 204 
Krox20 GCTACCCAGAAGGCATAATC 
TGACAGGAACGCAGAAGG 
62 90 250 
L27 GGTGGTTGCTGCCGAAATG 
ATCTCTGAAGACATCCTTATTGACG 
58-69 92 325 
     
Appendix 
 
 
116 
Human specific qRT-PCR primers continued  
Primer  Sequence (5’-3’) Annealing 
temp. 
Product 
melting temp.  
 
Product 
length 
Mash1 GTCCTGTCGCCCACCATCTC 
CCCTCCCAACGCCACTGAC 
63 92 251 
Nestin GGAGAAGGACCAAGAACTG 
ACCTCCTCTGTGGCATTC 
63 91 152 
Nkx2.2 ATGCCTCTCCTTCTGAAC 
TCAAGTGACGACATTAACG 
62 90 129 
Otx2 TGTGATCTCCTGTTATTGTATGC 
CTTCTCTTCTCTGACTCTCTTTG 
60 85 195 
Pax2 GCGACTCTCACAGCACAG 
CCACTCCACTCCTCCCATC 
62 87 288 
Pax3 ATGAAGCAAGAATGGAGGAATC 
CACAGGAAAGGGAAACAAGTC 
62 88 222 
Pax5 GCAGAATGTCATCCGAGGTATT 
ATGGCAGGTGTCCGAAGTG 
62 91 179 
Pax6 TACCAACGATAACATACCAAGC 
AGCCTCATCTGAATCTTCTCC 
63 90 264 
Pax7 GCGTGCTCAGAATCAAGTTC 
AGGTTCCGACTCCACATCC 
62 88 154 
Sox10 GAACAGGCTGGACAGAGGAGAAG 
AACAGGAGTCATAGGAGTGGTAAGG 
64 89 182 
Tubb3 CCGAAGCCAGCAGTGTCTAAACC 
GCAATAGATTTATTAAGTATCCC 
63 92 237 
vGlut1 ACCTCCATTCCACTCATCTC 
TTTGGGTATCCTTGAAACTGTC 
62 89 179 
vGlut2 AACCGCATCTACCCAAATACC 
TGAGAATGAGAATACAACAGAATAGC 
62 89 199 
 
11.6.2 Non human specific quantitative RT-PCR primers 
Primer Sequence (5’-3’) Annealing 
temp. 
Product 
melting temp.  
Product 
length 
CNP TGGCGCCCCTCCTCATCATGAGG 
CATCACGGTACTTGTCCAC 
61 90 241 
GAPDH ACGACCCCTTCATTGACCTAACT 
ATATTTCTCGTGGTTCACACCCA 
55-69 92 325 
HoxB1 GGGCTTGTCCGATGGCTACG 
GGTACTTGTTGAAATGGAACTCC 
63 90  122 
HoxB6 CGTGGATGCAGCGGATGAAT 
CAGCACCTTCACTCGGCCT 
62 88 297 
HoxC6 
(Takahashi et al. 2004) 
TCAAACGTGGACCTGAAAGTCA 
GGGAAAAGGGCCTGTAGACAA 
62 89 126 
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Non human specific quantitative RT-PCR primers continued  
 
Primer Sequence (5’-3’) Annealing 
temp. 
Product 
melting temp.  
Product 
length 
HoxC8 
(Takahashi et al. 2004) 
CGCACCACGTTCAAGACTTCT 
TAAGCGAGCACGGGTTCT 
62 90 81 
HoxD11 
(Hye et al. 2006) 
GCCTCCAACTTCTACAGCGC 
TTGAGCATCCGAGAGAGTTG 62 88 289 
Olig2 CAGAAGCGCTGATGGTCATA 
TCGGCAGTTTTGGGTTATTC 
63 90 207 
Telomerase TGGCTGCGTGGTGAACTTG 
GCGGTTGAAGGTGAGACTGG 
68 95 205 
TH CAGTTCTCGCAGGACATTG 
CGTCTGGTCTTGGTAGGG 
63 89 243 
 
11.6.3 Primers for COBRA assay 
Primer  Sequence (5’-3’) Reference 
Line fw TTGAGTTGTGGTGGGTTTTATTTAG (Yang et al. 2004) 
Line rev TCATCTCACTAAAAAATACCAAACA (Yang et al. 2004) 
 
11.6.4 PCR conditions 
Line PCR 
Time (seconds) Temperature (°C) Repeats 
30 95  
30 50  
30 72 35 
600  72  
 
Quantitative RT-PCR  
Time (min) Temperature (°C) Repeats 
3.00 95.5  
0.20 94.5  
0.20 Various  
0.50 72.0  
1.00 95.0  
1.00 55.0 35 
10 55.0  
 
PCR Mastermix (10ml)  
Reagent Volume (µl) 
PCR buffer (10x)  2000  
MgCl (50mM) 1200 
Each dNTP (100nM) 40 
SYBR Green (1: 10 0000)  15 
Fluorescein (100µM) 2 
ddH2O 6623 
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11.7 Animals  
Species Type Supplier Age 
Rat Wistar Charles-River P9 
Mouse C57 B6 Jackson Laboratories E10 – P3 
Mouse CD1 Jackson Laboratories E15 
Mouse  C57 B6 GFAP GFP (Nolte et al. 2001) P0 
    
 
11.8 Solutions and buffers: 
11.8.1 Cell culture 
CM (Conditioned Medium) 
 50ml hES Cell Medium without FGF-2 per 106 mitotically inactivated fibroblast 
 Incubation overnight at 37°C, 5% CO2 
 Store at -20°C 
 Add 4ng/ml FGF-2 prior to use 
 
EB-Medium 
FCS 20% 
Non-essential amino acids 1% 
L-Glutamine  1mM 
Knockout DMEM 80% 
 
hES cell medium 
Knockout serum replacement  20% 
Non-essential amino acids 1% 
L-Glutamine 1mM 
2-Mercapthoethanol 0,1mM 
FGF-2 4ng/ml 
In Knockout-DMEM 80% 
 
ITSFn medium 
Insulin 25µg/ml 
Transferrin 100µg/ml 
Sodium selenite 5ng/ml 
Fibronectin 2,5µg/ml 
FGF-2 20ng/ml 
In DMEM/F12  
  
MEF Medium 
FCS 10% 
Sodiumpyruvate 1% 
Non-essential amino acids  1% 
in DMEM  
 
N2 Medium  
N2 supplement  5ml 
Glucose 0,1g/ml 
Insulin  4ng/ml 
DMEM-F12 500ml 
Prior to use add 10ng/ml FGF,10ng/ml EGF and 1:1000 B27  
 
NGMC medium 
B27 1:50 
Cyclic AMP 100ng/ml 
N2 medium  50% 
Neurobasal medium 50% 
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R6-Medium 
Sodium sulfide 98mM 
Potassium sulfide 30mM 
Magnesium chloride 5.8mM 
Calcium chloride 0.25 mM 
Hepes 1mM 
Glucose 20mM 
Sodium hydroxide 0.125mM 
Phenol Red 0.001% 
 
Poly-ornithine (PO) 
Poly-ornithine 1,5mg/ml 
in ddH2O (Millipore, sterile)   
Coating of culture plates for at least 2 hours  
 
 
11.8.2 Western blot 
Laemmli sample buffer (2x) 
SDS  4% 
Glycerol 20% 
Bromphenol blue 0.004% 
Tris-HCl 0.125 M 
Prior to use add 20% 2-mercaptoethanol  
 
SDS-PAGE running gel (10%) 
dd H2O 2 ml 
30% acrylamide mix 1.7 ml 
1.5 M Tris HCl 1.3 ml 
10% SDS 0.05 ml 
10% APS 0.05 ml 
TEMED 0.002 ml 
 
Stacking gel 
dd H2O 1.15 ml 
30% acrylamide mix 0.33 ml 
0.5 M Tris HCl 0.5 ml 
10% SDS 0.02 ml 
10% APS 0.02 ml 
TEMED 0.002 ml 
 
5x Running buffer 
Tris 25 mM 
Glycin 956 mM 
SDS 0.5%  
H2O add 1000ml 
 
10x Transfer Buffer 
Tris HCl 250 mM 
Glycin 1.95 mM 
H2O add 1000ml 
Prior to use add 20% methanol 
 
Antibody blocking solution 
Tris-HCl pH7.5 10mM 
NaCl 150mM 
Tween 20 0.1% 
Skimmed milk powder 5% 
BSA 2% 
NaN3 10% 
H2O Add 200ml 
Aliquot and store at -20°C 
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PBS-Tween 
250µl Tween in 500ml PBS 
 
Blocking solution 
Skimmed milk powder 5% 
PBS-Tween 100ml 
 
 
11.8.3 Other 
Tris-Acetate-buffer 50x (TAE) 
Tris-Base 242g 
Acetic acid 570,1 ml (100%) 
add 5.0 M EDTA to a total volume of  100ml and adjust the pH to 8,0  
 
Agarose gel (1%) 
Agarose 0,5g 
TAE 1ml (50x) 
Dissolve in 49ml ddH20  
Ethidiumbromide  2µl 
add when cooled down and poor gel without creating bubbles into the gel chamber  
 
Fixative for FISH analysis and G-banding 
Methanol 243 parts 
Glacial acetic acid 111 part 
 
KCl (0.075M) 
KCl 24   5,6g/l 
H2O  
 
FACS buffer 
HBSS 1 part 
Hepes (pH 7,4) 2,5mM 
Glucose 30mM 
Calcium chloride 1mM 
Magnesium sulfide 1mM 
Sodium bicarbonate 4mM 
EDTA 1mM 
Penicillin/streptomycine  1x 
Add 500 ml destilled water 
 
Loading buffer 
EDTA 0,1M 
Sucrose 60% 
Bromphenol Blue 0,04% 
Xylene Cyanole 0,04% 
Ficole 2% 
H2O dd  
 
DMSO freezing medium 2x 
FCS 5ml 
DMSO 3,6ml 
dissolve in 22,8 ml DMEM-ES, aliquot and store at –20°C  
 
Sodium azide 
Sodium azide 1 mg/ml 
in PBS  
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11.9 Supplements 
Fibronectin (Fn 1µg/µl) 
Fibronectin 1mg 
dissolve in 1ml ddH2O, filter sterilize  (0,2 µm), aliquot and store at  –80°C  
 
Insulin stock (5 mg/ml) 
Insulin 1g 
dissolve in  200ml 10 mM sodium hydroxide, aliquot and store at  –80°C 
  
Sodium selenite stock (500 µM) 
Sodium selenite 86,5 mg 
dissolve in 10 ml ddH2O and store at –20°C  (100x) 
dissolve 150µl stock solution in 15 ml ddH2O,  aliquot and store at +4°C 
 
Progesterone stock (20 µM) 
Progesterone 0,32 mg 
dissolve in  50 ml EtOH abs. and store at  –80°C (100x) 
   mix 30µl of stock  with 3 ml EtOH, aliquot and store at  –80°C  
 
Trypsin/EDTA 1x (0,125%) 
10x Trypsin/EDTA 1ml 
dissolve in  9ml PBS, aliquot and store at –20°C  
 
Trypsin inhibitor (25 mg/ml) 
Trypsin inhibitor 500mg 
dissolve in 20ml PBS and store at  –20°C  (100x) 
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